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"And although I have seen nothing but black crows in my life, it doesn’t mean that there’s
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important not to reject the possibility of finding a white crow. You might almost say that
hunting for ’the white crow’ is science’s principal task."
Jostein Gaarder
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Abstract
Noroviruses are the major cause of acute viral gastroenteritis worldwide. Thus, rapid and
reliable pathogen detection and control are crucial to avoid epidemic outbreaks. Peptides
which bind to these viruses with high specificity and affinity could serve as small and
stable recognition elements in biosensing applications for a point-of-care diagnostic of
noroviruses. They can be identified by screening large phage display libraries using the
biopanning technique.
In the present study, this method was applied to identify norovirus-binding peptide motifs.
For this purpose, a biopanning based on column chromatography was established, and
three rounds of selections were performed. After the second round, the cosmix-plexing R©
recombination technique was implemented to enhance the chance of obtaining peptides
with very high affinity. Biopanning data evaluation was based on next-generation se-
quencing (NGS), to show that this innovative method can enable a detailed analysis of
the complete sequence spectrum obtained during and after biopanning. Highly enriched
motifs could be characterized by their large proportion of the amino acids W, K, R, N, and
F. Neighbourhood analysis was exemplarily performed for selected motifs, showing that
the motifs FAT, RWN, and KWF possessed the fingerprints with the largest differences
relative to the original library. This thesis thus presents next-generation sequencing-based
analysis tools, which could now be transferred to any other biopanning project. The
identified peptide motifs represent promising candidates for a future examination of their
norovirus-specific binding.
A new option for testing such phage-target interactions in the context of biopanning
selections was studied in the second part of the thesis. For this purpose, a phage-based
microarray was developed as a miniaturized binding assay. As a prerequisite, the different
immobilization behaviour of phages on positively and negatively charged surfaces was
studied, and a non-contact printing technique for bacteriophages was developed. Subse-
quently, the interaction of phages and antibodies directed against phage coat proteins
was characterized in enzyme-linked immunosorbent assays, and the protocol was success-
fully transferred to the non-contact printed phage spots. At the proof-of-concept level,
the phage array could finally be integrated into a microfluidic setup, showing a higher
signal-to-background ratio relative to the static phage array. These results point the
way towards a microfluidic phage array, allowing online monitoring, automation, and
parallelisation of the phage array analysis.
ix
Kurzfassung
Noroviren gelten als Hauptursache akuter viraler Magen-Darm-Erkrankungen. Nur eine
zeitnahe und verlässliche Detektion und Kontrolle dieser Pathogene kann epidemische
Ausbrüche vermeiden. Um dies zu ermöglichen, könnten Peptide, die an diese Viren
mit hoher Spezifität und Affinität binden, als kleine und stabile Erkennungselemente in
biosensorischen Anwendungen eingesetzt werden. Solche Peptide können mithilfe der
Biopanning-Technik identifiziert werden, die auf dem Screening großer Phagen-Display-
Bibliotheken beruht.
In der vorliegenden Arbeit wurde diese Methode genutzt, um Norovirus-bindende Pep-
tidmotive zu identifizieren. Dazu wurde ein auf Säulenchromatographie basierendes
Biopanning entwickelt und drei Selektionsrunden durchgeführt. Die Cosmix-Plexing R©-
Rekombinationstechnik wurde nach der zweiten Runde eingesetzt, um die Wahrschein-
lichkeit der Gewinnung hochaffiner Binder zu erhöhen. Die Auswertung der Biopan-
ningdaten erfolgte mittels Hochdurchsatzsequenzierung (Next-Generation Sequencing).
Es konnte gezeigt werden, dass diese innovative Methode die detailierte Analyse des
kompletten Sequenzspektrums während und nach dem Biopanning ermöglicht. Stark
angereicherte Motive konnten durch ihren hohen Anteil an den Aminosäuren W, K, R,
N und F charakterisiert werden. Eine Nachbarschaftsanalyse wurde exemplarisch für
ausgewählte Motive durchgeführt. Dabei wurden die stärksten Unterschiede im Fin-
gerprint im Vergleich zur Ausgangsbibliothek bei den Motiven FAT, RWN und KWF
gefunden. Diese Dissertation stellt damit auf Next-Generation Sequencing basierende
Analysetechniken vor, die für weitere Biopanningprojekte übernommen werden können.
Die identifizierten Peptidmotive könnten als vielversprechende Kandidaten zukünftig auf
ihre Norovirus-spezifische Bindung hin getestet werden.
Eine neue Möglichkeit, solche Phagen-Analyt-Interaktionen zu untersuchen, wurde im
zweiten Teil der Dissertation untersucht. Dafür wurde als miniaturisierter Bindungsassay
ein Phagen-basiertes Mikroarray entwickelt. Als Voraussetzung wurde zunächst das
unterschiedliche Immobilisierungsverhalten von Bakteriophagen auf positiv und negativ
geladenen Oberflächen untersucht und eine kontaktfreie Drucktechnik für Bakteriophagen
etabliert. Anschließend wurde die Interaktion von Phagen und gegen sie gerichteten An-
tikörpern in Enzym-gekoppelten Immunadsorptionstests charakterisiert und das Protokoll
erfolgreich auf die kontaktfrei gedruckten Phagenspots übertragen. Schließlich wurde
erstmals die grundsätzliche Möglichkeit gezeigt, das Array in ein mikrofluidisches Setup
zu integrieren, was zu einem höheren Signal-zu-Hintergrund-Verhältnis im Vergleich zum
statischen Array führte. Diese Ergebnisse zeigen damit den Weg zu einem mikrofluidis-
chen Phagen-Array auf, das sowohl die Möglichkeit des Online-Monitorings als auch der
Automatisierung und Parallelisierung der Phagen-Array-Analyse bietet.
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1 Motivation and Scope of the Thesis
Noroviruses are the leading cause of nonbacterial acute gastroenteritis - intestinal flu,
vomiting and diarrhea. Infections occur worldwide and affect individuals of all ages [1].
Especially in high-risk groups, such as the elderly, immunocompromised people, and
children in developing countries, noroviruses cause prolonged morbidity and mortality [2,
3]. Since the viruses are highly contagious, the infections often result in large and persisting
outbreaks, which can be hardly controlled [1, 4]. These outbreaks regularly occur in health
care settings (nursing homes for the elderly, hospitals) as well as on cruise ships, and in
hotels and restaurants [5]. The virus can even cause pandemic forms of gastroenteritis,
and thus cause considerable economic costs [4]. Therefore, noroviruses have a great impact
on public health, and are stated as a "global problem" [2].
Although rapid and reliable pathogen identification at gastroenteritis outbreaks would be
essential to avoid further infections and unnecessary antibiotic treatment, the current
diagnostic methods to detect noroviruses are limited in terms of sensitivity, specificity, or
economic efficiency [6]. In the last years, aptamers and peptides have come into the focus
of research as small and stable biorecognition elements for biosensing applications, which
offer advantages for pathogen detection such as rapid detection time and point-of-care
diagnostics [7]. Peptides which can bind with high specificity and affinity to the target
of interest can be selected from huge peptide libraries displayed on (bacterio)phages -
viruses that infect bacteria - using the biopanning screening technique. This method
consists of multiple rounds, in which phage-displayed peptide library and target molecules
are brought together with the objective to enrich target-specific phages, and to get rid
of target unrelated ones. Based on the selected phages, the sequences of the displayed
peptides can be concluded by identifying the corresponding DNA sequence in the phage
genome. For biopanning selections against noroviruses, norovirus like particles (NoVLPs)
can be used as target molecules, since they mimic native viruses without the risk of
handling infectious viruses [8].
This thesis was intended to study the applicability of a biopanning method based on
column chromatography (chromatopanning) to identify peptide sequences or motifs
specific against NoVLPs, and to enter into the very new research area of next generation
sequencing (NGS) analysis of the biopanning results. Usually, only a very limited number
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of phage clones selected in a biopanning experiment can be analysed using standard
Sanger sequencing. With NGS, huge sequence collections - virtually the entire phage
pool - can be characterized in a single run. Less enriched phage clones are also identified,
and changes in the copy number of clones can be observed from biopanning round to
round [9]. Moreover, the software used in this thesis for NGS analysis opened up additional
possibilities of analysing biopanning experiments.
The second focus of the present study was to pave the way towards a phage microfluidic
array as a miniaturized binding assay for testing phage-target interactions. Microarray
technology in general is based on biomolecules immobilized in an array format at micron
scale, which are probed with a sample to detect biomolecular recognition events [10]. Here,
the objective was to develop a proof-of-concept for a microarray based on bacteriophages,
and to analyse the binding of the immobilized phages to phage-specific antibodies. Finally,
this thesis was aimed at testing the integration of the phage microarray into a microfluidic
system for an increased automation of the process in shorter time and with reduced
reagent consumption.
The dissertation starts with explaining all fundamentals relevant for understanding the
performed experiments in chapter 2. Initially, the principle of biorecognition and the
different types of biorecognition receptors are briefly outlined. The main focus of this
chapter is on introducing noroviruses and current diagnostic technologies to detect theses
pathogens, and on presenting the phage display and biopanning techniques based on M13
bacteriophages. Crucial biopanning parameters are discussed, and the possibility to use
column chromatography and next-generation sequencing in the context of phage display
is introduced. The chapter finishes with a presentation of phage applications beyond
phage display, including the phage-based microarray technology.
Chapter 3 introduces microbiological materials and norovirus like particles (additional
materials are listed in the supplemental material), and gives an overview about all meth-
ods applied in this thesis.
The strategies and results of the chromatopanning experiments to identify NoVLP recog-
nition elements are presented and discussed in chapter 4. Special focus has been given
to the analysis of the biopannig selections by next-generation sequencing.
Chapter 5 describes and discusses all phage array related results, including high reso-
lution microscopy and printing of phages, the development of a positive control for the
array, and finally the integration into microfluidics.
A summary of the outcome of this thesis and an outlook on potential further studies is
provided in chapter 6.
2 Fundamentals
Molecular biorecognition requires two interacting partners. In the context of diagnostics,
one refers to a recognition receptor able to bind to the analyte of interest. This chapter
thus focuses first on introducing the principle of biorecognition. A second section will
present the target of interest, the norovirus, and three more will provide information about
the phage display technique applied in this thesis for developing recognition receptors.
The third section generally introduces the concept of phage display, whereas the next
one will give a more practical overview about the biopanning affinity selection technique.
The chapter is completed with an outlook on phage applications and an introduction to
phage-based microarrays.
2.1 Biorecognition receptors for diagnostics
Specific recognition and interaction between biomolecules or between biomolecules and
other molecules is a key issue for all biological processes. Antibodies recognize their
antigens, hormones bind to their receptors, and substrates and enzymes are interacting.
These biomolecular recognitions are typically reversible and based on multiple non-
covalent interactions, namely ionic and hydrophobic ones as well as hydrogen-bondings.
Furthermore, shape complementarity according to the key-lock-principle is also involved
in the biorecognition process [11, 12]. The binding event must not be understood to be
static, but more as an equilibrium of association and dissociation of the two interacting
partners [12].
The principle of biorecognition is the basis for many diagnostic applications. Biomolecular
recognition receptors are able to bind to a certain target molecule, and can be isolated
from nature or artificially engineered. They comprise all major classes of biomolecules:
proteins, nucleic acids, lipids and carbohydrates [12], but most applications refer to the
first two.
The field of receptors based on proteins range from short peptides to complex molecules
like antibodies, enzymes, lectins, or natural receptors [13]. Antibodies represent secreted
immunglobulins. They play a major role in our immune system by recognizing and
controlling a particular antigen. Antibodies consist of two heavy and two light chains
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forming a Y-shaped structure with a conserved, immunglobulin group-specific Fc region
and a hypervariable Fab end for specific antigen binding [14]. Although antibodies have
been employed as receptors in a great variety of detection purposes, they still have some
disadvantages. They are sensitive to changes in temperature or pH as well as to protein
modifications, and very small or toxic molecules can not serve as antigens. Animals are
usually required for antibody production by hybridoma technology, and thus, ethical
concerns have to be taken into account [15]. These disadvantages can be overcome by
synthetic peptide or antibody production using phage display technology [16]. Phage
display and the phage display-based biopanning affinity selection technique are in the
focus of this thesis. They can be employed to generate biomolecular recognition receptors -
short peptides as well as larger proteins, and are described in detail in section 2.3 and 2.4.
Nucleic acid-based receptors can be either single-stranded DNA to distinguish between a
wildtype and mutated counter strand, or aptamers. Aptamers are short, single-stranded
oligonucleotides, able to fold into three-dimensional structures specified by their sequence.
Just as peptides and antibodies, they recognize the target of interest primarily due
to shape complementarity and non-covalent interactions. Aptamers are selected from
libraries of oligonucleotides by a selection process called SELEX (systematic evolution
of ligands by exponential enrichment) [17], which is based on a similar concept as the
biopanning selection process for phage displayed peptides and proteins.
In summary, varying types of recognition receptors can be incorporated into diagnostic
assays or biosensors to detect the analyte of interest in environmental or clinical samples.
Since this thesis deals with receptors against noroviruses, the next section will characterise
these pathogens.
2.2 Norovirus
Noroviruses are the cause of more than 50 % of all gastroenteritis infections in children
and adults worldwide, and responsible for more than 90 % of all viral gastroenteritis,
often resulting in large and persisting outbreaks [18].
Until the early 1970s, all which was known about noroviruses was the discovery that a
typical acute nonbacterial infectious gastroenteritis could be transmitted to volunteers,
but an etiological agent could not be cultivated nor characterized. In 1971, Kapikian
et al. analysed a stool filtrate derived from an outbreak in Norwalk, USA, by immune
electron microscopy. Therefore the sample was mixed with inactivated serum of infected
volunteers as a source of specific antibodies. They were able to identify the infecting
agent, the "Norwalk virus", for the first time, as viruses and antibodies form aggregates
which can be visualized even if the viruses are small and in low concentration [19]. Today,
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much more is known about the Norwalk virus - now called norovirus, and the current
state of knowledge will be presented in this section.
2.2.1 Structure and physicochemical properties
Genomic structure
Noroviruses have a single-stranded, positive-sense RNA with a length of 7642 nucleotides
as genome. Figure 2.1 shows the organization of the sequence into three open reading
frames (ORFs), encoding a non-structural polyprotein as well as the major capsid protein
VP1 and the minor capsid protein VP2 [20]. The 5’-end of the RNA is linked to one of
the viral non-structural proteins, the virion protein genome-linked (VPg), whereas the
3’-end is polyadenylated [21].
Figure 2.1: Norovirus RNA organization in 3 open reading frames. ORF1 encodes a polyprotein
that is cut by the viral 3C-like protease to 6 non-structural proteins: p48, NTPase, p22, VPg,
3CLpro and RdRp. ORF2 and ORF3 encode VP1 and VP2, respectively [22, with minor
adaptions].
Structural proteins
In the 1990s, Prasad et al. studied norovirus particles by electron cryomicroscopy and
X-ray crystallography, and gave a precise description of their three-dimensional structure.
The norovirus genome is enclosed in a non-enveloped protein coat with distinct cup-
shaped depressions and a diameter of 38 nm. Like many other ssRNA viruses, noroviruses
exhibit an icosahedral symmetry with a triangulation number of T = 3 [23]. Their capsid
structure is formed by 180 molecules of the major capsid protein VP1, organized into 90
dimers, and one or two copies of the minor capsid protein VP2 [24].
VP1 has a molecular mass of 58 kDa and consists of two domains: a shell domain (S)
and a protruding domain (P), whereas P can be subdivided into P1 and P2. The P and
S domain are connected by a flexible hinge [25]. The P domain forms the protrusions and
is responsible for the dimeric interaction, and so enhances the capsid stability. The P2
subdomain is inserted into the P1 subdomain [25]. Since P2 has a hypervariable region,
it is assumed that it plays a crucial role in receptor interaction (see section 2.2.3) [24].
The structure of norovirus like particles - the norovirus protein shell without RNA - as
well as of the major coat protein VP1 is represented in Fig. 2.2.
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VP2 is a basic protein with a molecular weight of around 22 to 29 kDa. Its sequence
varies between norovirus strains [24]. VP2 is not essential for VLP assembly [26]. It
associates with the S domain of VP1 at the interior surface of the capsid and is thought
to play a role in assisting virus assembly and genome encapsidation [27].
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Figure 2.2: Structure of norovirus like particles (top: VLP surface from outside view; bottom:
VLP cross-section). The capsid consists of 90 dimers of the major capsid protein VP1 (right:
monomer, left: dimer) with an inward-looking N-terminal region (green), a shell domain
(yellow) and a protruding domain, subdivided in P1 (red) and P2 (blue) [28].
Non-structural proteins
The non-structural polyprotein is co-and posttranslationally processed by the only existing
viral protease, called 3C-like protease (3CLpro) to yield six non-structural proteins named
p48, nucleoside triphosphatase (NTPase), p22, VPg, 3CLpro itself, and RNA-dependent
RNA polymerase (RdRp) [24].
The N-terminal protein p48 has no sequence similarity to other viral or cellular proteins.
Its function is not well understood, but it might work as an intracellular protein trafficking
disruptor [29]. The viral NTPase has a NTP binding motif and hydrolyses all nucleoside
triphosphates [24]. p22 is on the same position in the norovirus genome as the 3A protein
in picornavirus genomes, which is essential for membrane localization of replication
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complexes, but the function of p22 is not clear so far [24]. VPg is covalently linked to the
5’ end of the RNA and most probably recruits ribosomes to the viral RNA to initiate the
translation [24]. As described above, noroviruses have a single protease called 3CLpro due
to its similarity to the 3C protease of picornaviruses. Like all RNA viruses, noroviruses
have a RNA-dependent RNA polymerase (RdRp), which synthesizes a negative-sense RNA
(antigenomic RNA) intermediate for genome replication [30]. The RdRp does not have a
proof-reading-activity and is therefore not able to repair mutations like DNA-polymerases
do. This is the main cause for antigenic drift (see section 2.2.2) [31].
Virus-like particles
Research on noroviruses is strongly limited due to the lack of cell culture systems or
practical animal models for virus cultivation. The only exception is a murine norovirus
which can be cultivated in cultured macrophages and dendritic cells [32].
Nevertheless, so-called virus-like particles (VLPs), mimicing native viruses apart from
having a RNA, can be produced using baculovirus expression systems in insect cells [33],
Venezualian equine encephalitis vector expression systems in mammalian cells [34], and
in a plasmid-driven system in the human endothelial kidney cell line HEK-293T [8].
Basically, the ORF2 capsid protein VP1 is expressed and able to self-assemble to virus
like particles, which can be used to carry out investigations on noroviruses without the
risk of handling infectious virus particles [8].
Physicochemical properties
The norovirus capsid shows a remarkable resistance to environmental changes. Ausar et
al. studied the effect of temperature and pH on the stability of virus-like particles and
came to the conclusion that they are stable over a wide pH range from 3 to 7 and resist
temperatures up to 55 ◦C. At pH 8, however, reversible capsid dissociation starts, and at
temperatures higher than 60 ◦C a heat-induced unfolding of the capsid occurred [35].
Furthermore, noroviruses are not inactivated by common cleaning detergents and al-
cohols [36], and remain stable at concentrations of chlorine at which the infectivity
of other viruses like poliovirus and rotavirus is strongly reduced [37]. They persist on
environmental surfaces like stainless steel as well as in food and water [5], but Warnes et
al. observed a rapid inactivation of noroviruses on copper alloy surfaces [36].
2.2.2 Classification and diversity
Noroviruses belong to the family of Caliciviridae. Due to phylogenetic analysis based on
the VP1 sequence, they can currently be classified into at least five major genogroups,
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Figure 2.3: Phylogenetic classification of noroviruses in five genogroups and various genotypes.
Norovirus genotypes infecting different species are listed in different colours (human: black,
porcine: green, bovine: blue, feline: red, murine: purple). GII.4 is subdivided into strains [5,
with minor adaptions].
each separated into numerous genotypes (see Fig. 2.3) [38]. Genogroups GI and GII are
responsible for the majority of human infections. GII.4 is the most important genotype,
being the only one which causes global pandemics of gastroenteritis [4]. Therefore it
is even subdivided into strains (sometimes called variants) [38]. The other genogroups
contain bovine (GIII), feline (GIV), canine (GIV) as well as further human (GIV) and
murine (GV) pathogenic strains. GII also contains porcine noroviruses [1]. A human
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population that is to a large extent resistant to one virus strain provides an environment
in which a selection for an escape from that herd immunity can take place [22]. So mainly
driven by immune pressure, norovirus strains undergo antigenic drift (mutations during
RNA replication) and shift (recombination between different norovirus genotypes or
strains), resulting in the evolution of new genotypes and a wide diversity of norovirus
strains [5]. Therefore, the dominant circulating genotypes change approximately every 3
years, and an individual person may be infected several times throughout life [4].
2.2.3 Norovirus infection: transmission and clinical features
Noroviruses are highly infectious, since only a low number of viruses (less than 1000,
even one infectious virus particle may be sufficient) may already cause an infection [39].
Moreover, due to their remarkable stability, they can remain outside a host for several
days [35]. Transmission of the viruses mainly occurs via the fecal-oral route and can
happen through direct person-to-person contact (single droplets containing viruses are
sufficient) as well as through environmental contamination, including foodborne and
waterborne infections [5].
The incubation time of a norovirus disease is only 10 to 51 hours. The infection often starts
with severe vomiting, other symptoms are abdominal cramps and diarrhae, and sometimes
fever, headache as well as myalgias and a general feeling of sickness [5]. Although clinical
symptoms usually last for only 2-3 days, patients with further diseases and young children
may suffer for a significant longer time (4-6 days) [18]. Especially young children, elderly
people and immunosuppressed patients also have a risk of mortality [2]. Estimated up to
200,000 deaths of children younger than 5 in developing countries are caused by norovirus,
as well as 900,000 clinical visits of children in industrialized countries [3]. Interestingly,
about one third of infected people does not show any symptoms [5]. Nevertheless, norovirus
shedding (excretion of viruses in human stools) continue for several weeks - regardless of
the presence of clinical symptoms during infection [40]. The treatment mainly consists
of rehydration, usually orally or, in severe cases, intravenously [5]. Furthermore, the
knowledge about potential targets for antiviral drugs has increased a lot, providing the
basis for their development [21]. Once the illness is overcome, only a weak and short-term
immunity against further diseases remain [5].
2.2.4 Human susceptibility to norovirus and the HBGAs
Many studies have been carried out to examine the correlation between histo-blood group
antigens (HBGAs) and human susceptibility to a norovirus infection. HBGAs are complex
carbohydrates which are present on the cell surface of erythrocytes and mucosal epithelial
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cells, and as free oligosaccharides in the intestine, in saliva, milk and blood [41]. The
norovirus binding site for HBGAs is on the surface of the P2 domain [42], and the virus
attach to its receptor in a multistep process [43].
The human HBGA system is very polymorphic with three important genetic factors:
AB0, Lewis- and Secretor type. Different norovirus strains bind to different HBGAs and
therefore several HBGA-binding profiles have been described [44]. Additionally, humans
which are homozygous recessive for the α(1,2)fucosyltransferase gene (FUT2 ) do not
express FUT2-dependent HBGAs (A, B, H, Lewis b, and Lewis y antigens) and are
defined as nonsecretors. They can only express Lewis a and x and are protected from
the majority of norovirus infections [45, 46]. Epidemiological important GII.4 strains
bind more HBGAs and are able to bind to receptors of nonsecretors [47]. Nevertheless,
Murakami et al. reported that norovirus attachment and internalization can happen
independently of HBGAs [48].
As a conclusion, all these studies suggest that a particular norovirus strain is only able
to infect a subset of the population, but since the HBGA-binding affinities of noroviruses
are diverse, each individual might be susceptible to at least one norovirus strain [22].
2.2.5 Replication cycle of noroviruses
Although the replication cycle of caliciviruses in general, or noroviruses in particular,
is not fully understood, it can be described schematically in 11 steps and is presented
in Fig. 2.4 [21]. Initially, the virus capsid attaches to its cellular receptor and the
virus is internalized through endocytic vesicles (1). It may survive the pH drop in
the vesicles, but after release into the cytoplasm, the viral RNA (genomic RNA) is
uncoated (2) [21, 35]. As a next step, the VPg linked to the genomic RNA interacts
with cellular initiation factors and ribosomes, and the translation to produce the viral
polyprotein is initiated (3). Co-translational processing of the polyprotein leads to the
the release of the non-structural proteins (see section 2.2.1) (4). These proteins are
thought to form a replication complex (5) for the synthesis of antigenomic RNA (6).
Now the antigenomic RNA can act as at template for the production of genomic (7),
and subgenomic RNA (8). The new genomic RNA can be used to obtain further viral
polyproteins (see step 3) or it can be packed into freshly assembled viral capsids (see step
10).
The subgenomic RNA is translated as structural proteins (9), which can then assemble
and form new viruses together with the genomic RNA (10). Finally, the viruses are
released from the cell (11) [21].
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Figure 2.4: Replication cycle of noroviruses. The multiplication cycle can be described in 11
steps: (1) Attachment and internalization of the viral particles, (2) uncoating of the genomic
RNA, (3) translation of the polyprotein, (4) its co-translational processing to obtain the
non-structural viral proteins, (5) formation of a replication complex for (6) production of
the antigenomic RNA, (7) the antigenomic RNA acts as a template for synthesis of genomic
RNA and (8) subgenomic RNA, (9) translation of subgenomic RNA for the production of
structural proteins VP1 and VP2, (10) assembly of structural proteins and packaging of
genomic RNA, (11) release of viruses from the cell [21, with minor adaptions].
2.2.6 Diagnostics - state-of-the-art
Rapid and reliable pathogen identification at gastroenteritis outbreaks is essential to
limit further infections and unnecessary antibiotic treatment [6]. Detection of noroviruses
is usually based on the examination of stool samples, but contaminated environmental
samples like food can be tested as well [49].
Electron microscopy
Until 1993 electron microscopy was the only technique to identify noroviruses in stool
samples by means of their morphology [5]. Direct electron microscopy requires at least
106 viral particles/ml for detection [50]. This high concentration can only be found during
the very early stage of a norovirus infection, this has to be taken into account when
collecting samples [49]. In many countries electron microscopy is still used in public health
laboratories, but due to the very low number of viruses in stool samples it is relatively
insensitive and requires highly experienced microscopists and expensive equipment [51].
As a variation immune electron microscopy can be used to detect immune complexes
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of virus and serum antibodies, as it was applied for the discovery of noroviruses [52].
Although the sensitivity is improved, the majority of contaminated samples is still tested
false-negative due to the low virus concentration, and it is laborious as well [51].
Reverse transcriptase PCR
Sequencing of the norovirus genome in 1990 [53] allowed the development of reverse
transcriptase polymerase chain reaction (RT-PCR) for norovirus detection [51]. The viral
RNA is first transcribed into its DNA complement by reverse transcriptase. The DNA can
then be amplified using norovirus-specific primers. Due to the great diversity of norovirus
strains, a collection of primers has to be used, and not all strains can be detected in a
single assay [54]. RT-PCR is followed by Southern hybridization or sequencing of the
PCR products to diagnose norovirus [51]. RT-PCR assays are laborious and expensive,
but highly sensitive, detecting 102-104 viral particles/ml, and are considered to be the
reference method for norovirus detection [5, 49]. Many different assay formats have been
developed. Real-time RT-PCR is faster and more sensitive and is now replacing the
RT-PCR in clinical diagnostics [55]. A multiplex RT-PCR can detect different viruses
simultaneously [56], and multiplexing and real-time detection can even be combined in a
single assay for the identification of different norovirus strains [57, 58] or the simultaneous
detection of 12 different bacteria and viruses [59]. Further assay formats are a rapid
miniaturized RT-PCR in a microfluidic system [60], and a nested RT-PCR for higher
sensitivity [61].
Immunoassays
Enzyme-linked immunosorbent assays (ELISA) are cheaper and easier to perform than
electron microscopy and RT-PCR [6]. They are based on the detection of norovirus proteins
by antibodies, and a virus concentration of 104-106/ml is necessary for detection [49].
Currently there are three commercial kits available, the SRSV(II)-AD by Denka Seiken
Co. Ltd., the IDEIA Norovirus kit by Oxoid, and the RIDASCREEN R© Norovirus 3rd
Generation enzyme immunoassay by R-biopharm AG. All tests were rated to be clearly
less sensitive and less specific than RT-PCR and only useful for a preliminary screening
in which negative-tested samples are re-checked by RT-PCR [62–64].
Novel diagnostic reagents and biosensors
The studies described above show that there is a strong need for the development of
sensitive and specific receptor molecules, which could be used in ELISA as well as in
biosensors, reaching from new antibodies to aptamers and peptide receptors.
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In the last years, several novel monoclonal antibodies reacting against norovirus strains
were identified, some of them interact cross-reactively with different genogroups [65, 66].
A recent development, the RIDA R© QUICK immunochromatographic detection assay
based on antibodies, was rated to be fast and to have high sensitivity and specificity at
least for GII noroviruses [67].
Single-chain variable fragment (scFv) antibodies produced by phage display (see section
2.3) avoid the use of mice and standard hybridoma technique. Antibody fragments that
bind to GI and GII VLPs were successfully tested to detect norovirus in clinal samples in
an ELISA assay [68]. Monoclonal antibodies [69], Llama-derived single-chain antibody
fragments (so-called nanobodies) [70], and phage-display derived antibodies [71] could
potentially also be used for therapy and immunoprophylaxis.
Aptamers and peptides (see section 2.1) as stable and inexpensive alternatives to antibodies
are currently in the focus of research. A promising DNA aptamer was developed against
murine norovirus. It also binds to human GII.3 VLPs and was successfully incorporated
into an aptasensor platform [72]. Other selected DNA aptamers target GII.2 Snow
Mountain and GII.4 VLPs [73], or GII.4 P-particles [74]. Finally, Rogers et al. reported
about the selection of peptides by phage display which are able to bind to VLPs and to
detect them also in clinical stool samples [75].
2.3 Phage display
Phage display, and biopanning based on it, are the key methods in this thesis. This
section will focus on bacteriophages as the tool for these techniques, and the principle
and different aspects of phage display.
2.3.1 Introduction to bacteriophages
By the end of the 19th century, the british bacteriologist Ernest Hanbury Hankin reported
about the antibacterial activity of indian river waters against cholera, but it took 20
more years until bacteriophages - viruses that infect bacteria - were actually discovered
by Frederick Twort in 1915 and Félix d’Hérelle in 1917, respectively. Bacteriophages play
a unique role in biology. They are the most abundant living entities in the biosphere: a
global population of more than 1031 phage particles regulates the microbial balance of
our ecosystems [76, 77].
Bacteriophages have DNA or RNA as genetic material, which is enwrapped in a protein
coat [78]. Like all viruses, they do not have an own metabolism, but are fully dependent
on their bacterial host. There are different types of bacteriophage morphology. The by
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far biggest group are the tailed phages with a dsDNA as genome, like the extensively
studied phages Lambda, T4 or T7. They account for 3 of the 10 phage families, but
represent over 96 % of all phages. The other 7 families consist of phages lacking a tail
and having a RNA or ssDNA genome [79]. One of these families is called Inoviridae and
contains filamentous - very long and thin - bacteriophages with a ssDNA genome. The
best-known members of this group are the Ff phages, including f1, fd and M13 phages.
They only infect gram negative bacteria bearing the so-called F episome, a plasmid
allowing horizontal gene transfer from one bacterium to another [80].
2.3.2 Biology of M13 phages
For phage display in general, and for this thesis in particular, M13 is the most important
bacteriophage. The whole group of Ff phages have several advantages for phage display
applications. Their genome is small and able to tolerate the insertion of foreign DNA
fragments, modifications of the phage coat proteins do not necessarily reduce phage
infectivity, they are stable under a wide range of environmental conditions, and easy to
propagate [81].
Phage structure
M13 phage particles are flexible rods with a length of 930 nm and a diameter of 6.5 nm.
They consist of a single-stranded DNA genome coated in a protein shell. The ssDNA
with a size of about 6400 nucleotides codes for 11 different proteins [82]. As shown in
Fig. 2.5, the phage coat contains five different proteins. The other six gene products are
essential for phage DNA replication and assembly (see below) [83]. PVIII is the major
coat protein consisting of 50 amino acids - 2800 copies are wrapped around the DNA in
helical symmetry [84]. The ends of the phage particle are capped with minor coat proteins:
5 copies each of pVII and pIX on one end, and 5 copies each of pIII and pVI on the other
one [85]. PVII and pIX are hydrophobic peptides, required for starting phage assembly
by deposition of pVIII proteins, whereas pIII and pVI are essential for terminating the
assembly and for the interaction to the host cell. The total viral mass is 16.3 MDa [86].
Replication cycle
M13 phages infect their host Escherichia coli by adsorbing to a bacterial appendage called
F-pilus, which is encoded on the F episome (see above). The N-terminal domain of pIII
interacts with the tip of the pilus. The phage then approaches the bacterial membrane
by depolymerisation of the pilus. Whereas the pilus is the primary receptor for pIII, the
second N-terminal domain of this protein binds to the TolQRA complex in the bacterial
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Figure 2.5: Schematic structure of a filamentous M13 phage. The circular single stranded
genome on the right encodes the information for 11 phage proteins. Whereas 6 proteins are
essential for phage DNA replication and assembly, the other 5 proteins form the phage capsid
shown on the left, with pVIII as the major coat protein and pIII, pVI, PVII and pIX as
minor coat proteins [83].
membrane as a secondary receptor. The phage coat proteins are now able to dissolve
into the membrane and the phage ssDNA is translocated into the cytoplasm by the help
of the pIII C-terminal domain [80].
Inside the cell, the complementary phage DNA strand is synthesized by bacterial en-
zymes and a double-stranded replicative form (RF) molecule is produced. Transcription
and translation of this DNA template lead to the production of new phage proteins.
Some of them are involved in the synthesis of new ssDNA molecules by "rolling-circle"
replication [87]. With more ssDNA molecules, the copy number of dsDNA increases
and thus more phage proteins are produced. Coat proteins and proteins important for
phage assembly are integrated into the bacterial membrane, whereas proteins for DNA
replication remain in the cytoplasm.
Later in infection, a certain concentration of the phage ssDNA binding protein pV is
reached. This protein forms a complex with the ssDNA molecule, resulting in the assembly
of new phage particles at the bacterial membrane with the assistance of phage assembly
proteins and one bacterial protein. Coat proteins assemble around the DNA until the
end of the phage DNA is reached. New phages are extruded through the bacterial
membrane [80]. Depending on conditions, 200 to 2000 phages are produced per bacterial
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cell per doubling time [88]. The phage assembling process does not inhibit the bacterial
growth or replication, but only slows it down [82].
2.3.3 Principle of phage display
The presentation of heterogenous peptides or proteins on the surface of bacteriophages is
called phage display and was initially developed and described by George Smith in 1985
("Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on
the Virion Surface") [89]. The marvellous idea behind is the linkage between genotype
and phenotype of the phage: a foreign DNA encoding the information for the peptide or
protein is inserted into the genome of the phage and so this peptide or protein is expressed
as a fusion to one of the coat proteins of the phage. It can be displayed at the amino
terminus of either the pIII or pVIII coat protein [81]. Furthermore, new display formats
using pVI, pVII or pIX have also been developed [90]. If the foreign DNA insert carries a
randomized sequence, each phage will present a different peptide. Such a broad diversity
of phages - more than 1011 variants are possible - is called phage display library [87].
These random libraries can be used to identify peptides which are able to bind to a certain
target molecule in an affinity selection process called biopanning. This is thoroughly
described in section 2.4.
2.3.4 Phage display systems
Several display systems have been developed so far. Besides phage display, there is also
bacterial and yeast display. Systems based on other bacteriophages (T4, λ) are promising,
too, but as stated above, M13 phages are the most commonly used phage vectors for
phage display [90]. Hence, in this section M13 phage display systems will be described in
more detail.
M13 pIII and pVIII are the most important coat proteins for phage display [81]. The
foreign peptide or protein is fused to the N-terminus of the respective coat protein. This
exposure to the environment facilitates the interaction with target molecules as it is
needed during biopanning [86].
Types of phage display systems
Phage display systems can be classified regarding the location where the foreign DNA
fragment bearing the information for the peptide is inserted. The different types are
compared in Fig. 2.6. In a type 3 phage vector, each phage, as naturally, only has one
DNA genome with one gene III. The exogenous DNA insert is fused to this gene. So in
theory the foreign peptide is displayed on all five pIII coat proteins, being referred to as
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Figure 2.6: Types of phage display systems. Phage particles (vertical ovals, white circles
represent pIII) with phage DNA (twisted line) are shown. Black box: gene VIII, white box:
gene III, crosshatched part of box: foreign DNA insert, crosshatched circle on phage surface:
displayed peptide. Type 3 and 8 represent polyvalent display, whereas all other types belong
to the monovalent display system [91].
polyvalent display. In reality, there is the risk that some of the foreign peptides might
be removed by bacterial enzymes, but nevertheless, avidity effects have to be taken into
account during binding [91, 92]. A type 33 vector has two genes III in the phage genome -
a wild-type form and one including the DNA insert. Both types are expressed, so less pIII
coat proteins will display the foreign peptide (monovalent display). A type 3+3 system
consists of two separated genes III: the wild-type form belongs to the so-called "helper
phage", whereas the recombinant one is located on a plasmid named "phagemid" [91]. The
resulting phages are again mosaics, displaying a mixture of wild-type and recombinant
pIII proteins. Since phagemids were used in this thesis, they are explained in more detail
in section 2.3.4. PVIII phage display systems can be classified accordingly (type 8 , type
88 , type 8+8 ), but polyvalency can reach a much higher level than with the five copies
of pIII [91].
Phage display libraries
Biopanning is the most common application for phage display, and so systems based on
randomized (hypervariable) oligonucleotide inserts are necessary, resulting in the display
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of peptides with a random amino acid sequence. Different peptide/protein lengths can
be presented - from a low number of amino acids up to antibody fragments [90]. In pVIII
based libraries up to 2700 copies of the peptide can be displayed on one phage particle.
These libraries are more appropriate for very small peptides, since bigger inserts interfere
with coat protein fuction. A workaround for this issue is the use of type 88 or type 8+8
systems, respectively. In pIII libraries, up to 5 copies of large peptides can be displayed
per phage without interfering with phage infectivity or assembly [86].
Display of small peptides allows for searching binders to a certain target, where a short
continuous amino acid sequence is important for the interaction. Larger peptides instead
may reflect an interaction site where widely separated amino acid residues are essential
for binding [81]. It is also possible to display random peptides with cysteine residues on
fixed positions. Due to the disulfide bridges between two cysteines, peptide "loops" will
be formed. These peptide formats are called conformational constraints [86].
Antibody libraries are based on the insertion of the variable (V) and constant (C) domain
genes of the light and heavy chains of antibodies, producing Fab fragments (fragment
antigen-binding), or the cloning of only the variable domains of both chains, connected by
a flexible linker, resulting in the presentation of single-chain variable fragments (scFv) [81].
Furthermore, there are genomic libraries, having fragments of chromosomal DNA of one
organism as inserts, and cDNA libraries, with DNA copies of messenger RNAs of a certain
tissue or cell culture as inserts [91].
Phagemids
Phagemids are plasmids (small, double stranded, mostly circular, and autonomously
replicating DNA molecules). As shown in Fig. 2.7, they have one origin of replication of
a plasmid, and therefore can replicate as double strands like a normal plasmid. Since
they also have a f1 origin of replication from a f1 bacteriophage, they can replicate
as single strands and can be packaged into phage particles. Additionally, phagemids
contain an antibiotic resistance gene enabling selection of bacteria which contain the
phagemid. Foreign DNA fragments can be cloned into these plasmids. For phage display
applications, they encode one coat protein gene fused to the DNA insert for the peptide
to be displayed, and to the gene for a signal peptide which directs the secretion of the
coat protein to the bacterial inner membrane. This recombinant coat protein is controlled
by a regulated promotor [93]. For completing the phagemid life cycle, all other functional
and coat proteins of the phage have to be provided by the so-called helper phage. For
this purpose, bacteria carrying the phagemid have to be superinfected by a helper phage.
Then all proteins necessary for phagemid ssDNA replication and packaging as well as
all other coat proteins are provided by the helper phage, and only the recombinant coat
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Figure 2.7: M13 phagemid structure (top) and application in phage display (bottom). The
phagemid contains two origins of replication (f1 ori for ssDNA replication and 332 ori for
dsDNA replication), a selective marker (Ampr coding for ampicillin resistance), and the insert
for the protein to be displayed fused to the gene for a M13 coat protein with an upstream
promoter and secretion signal. For phage display, helper phages are added to E. coli carrying
the phagemid. Phagemid ssDNA can now be packed into phage particles resulting in the
display of the protein of interest on the phage surface [90].
protein comes from the phagemid. This results in mosaic particles, where recombinant
and wild type coat proteins are displayed on the same phage. To avoid packaging of
helper phage DNA instead of phagemid DNA into the new particles, most types of helper
phages have a defective origin of replication or packaging signal [94, 95]. Phagemids
offer several advantages over phages as vectors in phage display. Their small genomes
allow the insertion of a larger foreign DNA fragment, and the availability of a variety of
restriction enzyme recognition sites simplifies cloning. Due to their higher efficiency in
transformation, the diversity of the library can be increased. Finally, phagemids have a
higher genetic stability than recombinant phages [95].
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2.4 Biopanning: screening phage display libraries
Phage display libraries can be screened for phage clones with binding affinity to the
target of interest - this screening technique is referred to as biopanning [81]. Fig. 2.8
illustrates the basic principle of biopanning: initially, the phage display library (or later,
the enriched phage pool from the previous biopanning round) has to be incubated with
target molecules. Unbound phages are then removed by washing, and retaining phages
are separated by elution. Selected phages can now be amplified for the next round of
biopannning by infecting their bacterial host. After the last round, phage clones or
the whole phage pool are analysed to identify the phages with binding affinity to the
target [81]. Binding tests which are commonly used are immunological methods like
ELISA and surface plasmon resonance (SPR).
Whereas the last section has focused on the background of biopanning, the phage display
technology itself, this section will give a more practical introduction to the biopanning
screening method and what has to be taken into account when performing a biopanning
experiment.
phage library incubation of phages 
and target
elimination of unbound phages 
by washing
elution
amplification of phages
analysis:
selection of single phage clones for 
sequencing and binding tests or next 
generation sequencing of phage pool
Figure 2.8: Basic principle of the biopanning selection technique. One round of biopanning
consists of the following steps: a phage library is incubated with target molecules, then
unbound phages are eliminated, whereas bound phages survive this process. They are eluted
for amplification to carry on with the next round of biopanning or to start analysing the
retained binders.
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2.4.1 Crucial biopanning parameters
Since biopanning is like "searching the needle in the haystack", the selection does not
necessarily have to end successfully [96]. There is always the risk to enrich target-unrelated
phages. These phages can be divided into unspecifically binding or propagation-related
ones. Unspecific binding phages interact with the so-called background of the screening
system: the solid phase, blocking agents, contaminants of the target sample and so on.
Known background binders were described by Vodnik et al. [96]. Furthermore, phages
having an advantage in propagation (increased infectivity or phage particle production)
can predominate in the phage pool after some rounds of biopanning although they do
not have a high affinity to target or background [96].
In biopanning, two competing criteria have to be taken into account. On the one hand,
there is the wish to remove all target-unrelated phages. They bind to the target or to the
background with low affinity, but they are present at high concentration. On the other
hand, the few best binding phages have to be retained [97]. This is only possible with an
optimal stringency (pressure of selection) during the biopanning rounds.
Library diversity and cosmix plexing R©
In general in can be said that the more variants a phage display library contains, the
higher is the chance to find an appropriate binder to the target of interest. Library
diversity usually ranges from 107 to 1011 different peptides/proteins which are presented.
But this large diversity is minute in relation to the theoretically possible variety (as an
example: 3.276 x 1019 variants for a peptide with 15 amino acids (15mer)). However, the
creation of larger libraries is practically limited [97].
One possibility to enhance the chance of selecting peptides with very high affinity is
the recombination of the enriched peptide sequences, called cosmix-plexing R©. Here,
the randomized peptide sequence of the phage library is subdivided into two or three
hypervariable cassettes of three to six amino acids. These variable cassettes can be
arranged in all combinations. The only requirement for cosmix-plexing R© is a short
homologous stretch of two base pairs in the randomized sequence. For recombination
of the cassettes, the phagemid bearing the hypervariable sector has to be cleaved into
fragments. Therefore, restriction sites are inserted next to the cassettes. Restriction
enzymes are chosen which are able to recognize these special sequences and to cut the DNA
outside the restriction site, namely at the recombination site between the cassettes. The
recombination site can be one of six possible dinucleotides. They are all non-palindromic,
ensuring that only correctly oriented cassettes are reassorted during recombination. Thus,
the open-reading frame is maintained, and theoretically, all sequences produced can be
translated [97]. Before cosmix-plexing R©, one or two rounds of biopanning are carried out
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Figure 2.9: Cosmix-plexing R© protocol consisting of cleavage of the phagemids at their recombi-
nation (plexing) sites, religation to concatamers, cleavage of the concatamers at the resolution
sites, and production of recombined phagemids [97].
to pre-select potential binding sequences. As shown in Fig. 2.9, phagemid DNA is then
isolated and cleaved at the recombination site by a restriction enzyme. The obtained
fragments are re-ligated by a DNA ligase at high DNA concentration, resulting in long
DNA molecules consisting of numerous phagemid DNAs in a row (concatamers). The
concatamers are subsequently cleaved by another enzyme at a different site, the resolution
site. Individually circularised phagemids - now recombined - are finally produced by
ligation at low DNA concentration, and can be used in subsequent rounds of panning [97].
Selection strategies
Targets can be presented on a substrate (solid-phase biopanning) or in solution (solution-
phase biopanning). For solid-phase biopanning, target molecules are immobilized on a
surface, either unspecifically by simple adsorption to functionalised microtiter plates,
tubes, or beads, or specifically by covalent binding. Specific immobilisation does not
have the risk to change the protein conformation and in some cases allows reversible
binding, e.g. poly-histidine-tagged targets bind to chelated nickel ions, but can be eluted
by imidazole [81, 92]. The interaction of target molecules and phages can alternatively
take place in solution, but has to be followed by an affinity capture step to isolate the
phage-target complexes. So for example polyhistindin-tagged targets will bind to chelated
nickel beads, biotin-labeled molecules can be captured by streptavidin-agarose beads, and
for antibodies as targets Protein A or G beads can be used. Solution-phase biopanning
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with affinity capture entails the same advantages as specific immobilization at a surface.
To avoid background binders, target presentation can be varied from round to round, and
unoccupied reactive sites of the surface or beads should be blocked by a suitable blocking
reagent [98].
Instead of isolated target molecules, either immobilized or in solution, biopanning can be
also performed in more complex matrices like cells which present the antigen, or even
in whole tissues or animals (in vivo screening) [99]. A very crucial parameter for the
selection of phages with binding affinity to the target is the ratio of phages to target
molecules. At a low target concentration phages have to compete for binding and thus
the stringency is increased. Higher stringency is also achieved by monovalent display
(see 2.3.4) [91]. Higher target concentrations may on the other hand also lower the risk
of selecting background binders, but the selection will favour phages which are more
abundant and bind with low affinity instead of rare high affinity binders [96].
Binding conditions
Several variables concerning the binding buffer, in which the interaction of peptides and
target molecules takes place, are important for optimal binding conditions. Salt concen-
tration of the buffer has to be considered, since hydrophobic peptide-target interactions
dominate in a high salt buffer (high ionic strength), but ionic interactions are favoured in
a low salt buffer (low ionic strength). Furthermore, unspecific hydrophobic interactions
are diminished by the addition of a detergent to the binding buffer [98].
Washing conditions
In the first round of biopanning washing conditions are usually less stringent to retain
all binding phages, but in later rounds intense washes will lead to a higher stringency of
selection with the aim to only select the best binding phages [81]. Washing parameters to
play with are the number and duration of washing steps as well as the concentration of
detergent.
Elution conditions
There are basically two possibilities to elute bound phages after washing, the nonspecific
elution and the specific one. Nonspecific elution has the aim to weaken the interaction
between target and peptide in an unspecific manner. Conditions are chosen which do
not interfere with phage infectivity. Often an acidic buffer (pH 2.2) with subsequent
neutralization is used [91, 98]. Other options include the addition of urea or infection
with E. coli. Protease digestion or reduction detaches the phages if a protease recognition
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sequence or a disulfide bridge, respectively, has been included [99]. In the optimal case,
a specific elution with a known target ligand is possible. Here, the risk of eluting
target-unrelated phages is decreased [91].
Number of biopanning rounds
Since the pool of phages has to compete for binding in each round of selection, phages
binding to the target will hopefully be enriched more and more with each new round.
Usually 3 to 4 rounds are required to obtain a consensus sequence [98, 99].
Negative screening
Negative or subtractive selection intends to get rid of unspecifically binding phages by
performing a biopanning round in the absence of target and carrying on with the phages
that did not bind to the background and could therefore be washed off [99]. Phages should
not be amplified after negative screening before starting the next biopanning round to
avoid propagation-related nonbinders [96].
2.4.2 Column chromatography for biopanning
Chromatography is a separation method which can also be used for biomolecules. It is
based on a mobile phase containing the molecular species of interest, which run through
the stationary phase. For column chromatography, the stationary phase is a porous
matrix packed in a column. Biomolecules are separated and purified due to differences
in a certain property, e.g. their net surface charge for ion exchange chromatography
(IEX) [100] or their ligand specificity for affinity chromatography [101]. The sample
of interest is loaded on a column and molecules able to bind to the column matrix
remain while all non-binding proteins pass through. In IEX, the chromatographic matrix
is supplemented with charged functional groups: positively charged groups for anion
exchangers, negatively charged ones for cation exchangers. Biomolecules now show
different degrees of interaction according to their net surface charge, which is of course
pH dependent. A protein which is uncharged at a pH equivalent to its isoelectric point
(pI) does not interact with a charged matrix, but will bind to positively charged groups
(anion exchanger) at a pH higher than its pI, and to negatively charged groups (cation
exchanger) at a pH lower than its pI [100]. In affinity chromatography the matrix is
supplemented with a specific ligand able to reversibly bind the biomolecule of interest.
Interactions that can be used are e.g. antibody - antigen, enzyme - substrate analogue,
hormone - receptor, and metal ions - poly-histidine-tagged proteins.
After loading the sample and washing the column to remove all non-binding material,
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Figure 2.10: Principle of ion exchange chromatography (IEX) [102]. After equilibration of the
chromatographic system and sample application onto the column, unbound molecules are
removed during washing. A NaCl gradient is used to elute bound material. Each peak
represents a certain protein species. A final high salt wash removes all tightly bound material
before re-equilibration of the column starts. The flow-through volume is indicated in column
volumes (cv). For a 1 ml column, 1 cv corresponds to 1 ml.
conditions are changed to elute bound molecules. In ion exchange chromatography,
proteins are eluted by increasing salt (NaCl) concentration of the buffer. The ionic
strength raises and Na+ and Cl− compete with the retained sample for binding to the
charged matrix surface. The protein with the lowest net charge at the particular pH will
be the first to be eluted, but the higher the net charge is, the higher will be the salt
concentration needed to recover the protein [100].
In affinity chromatography the molecules of interest are recovered by a competitive
ligand. The process can be monitored and visualized in a chromatogram by measuring
the UV/Vis signal of the biomolecules eluted from the column as well as the conductivity
of the sample to observe changes in salt concentration. A schematic chromatogram is
shown in Fig. 2.10 for IEX [100] and in Fig. 2.11 for affinity chromatography [101].
Chromatography may be preparative: the biomolecules of interest can be recovered for
further use by a fraction collector. The eluate is divided into fractions which can be
assigned to a certain peak in the chromatogram.
Biopanning can be based on chromatography if experimental conditions are found in
which the target molecules bind to the chromatography column, but the phages pass
through. Since they are negatively charged, they can be purified by an anion exchange
chromatography [103], but are not expected to bind to a cation exchange column.
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Figure 2.11: Principle of affinity chromatography [101]. Similar to IEX, the column is equi-
librated in binding buffer and the sample is applied. Unbound material is washed away
and the binding buffer is changed to elution buffer, which contains a competitive ligand to
specifically elute the bound proteins. When all material of interest is recovered, the column
can be re-equilibrated. The flow-through volume is indicated in column volumes (cv).
Whereas traditional biopanning selections are based on adsorption and desorption of
phages and target molecules in a batch equilibrium, chromatographic biopanning allows
multiple equilibrium stages [104]. Moreover there is the chance to monitor the biopanning
process, since phages can be detected during chromatography by UV at around 280
nm. Up to now, there are only few research groups combining biopanning selections and
chromatography techniques. Nian et al. stated to be the first performing biopanning in a
chromatographic procedure. They were able to identify peptides highly specific for Pb2+,
using monolithic column chromatography [104].
2.4.3 Next-generation sequencing for biopanning
After enrichment of phages in biopanning, researchers aim to know the sequences of their
randomized inserts to predict a consensus motif. This is usually achieved by isolating
the DNA of single phage clones and a subsequent Sanger sequencing. This technique
was developed in 1977 by Sanger et al. and is based on the sequencing of DNA by
chain termination [106]. It became the predominant sequencing method for the next 30
years [107]. Although automation solutions have become possible, Sanger sequencing is
labour-intensive and therefore in phage display applications not used for more than a
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Figure 2.12: Illumina sequencing technology [105, with minor adaptions]. (1) DNA fragments
are attached to adapters prior to sequencing. (2) DNA is then denatured to obtain a pool
of single-stranded fragments, which are randomly attached to complementary primers on
the surface of a flow cell via the adapters. (3) Solid-phase amplification is initiated by the
addition of nucleotides and enzymes, to (4) form double-stranded bridges to primers nearby.
(5) Denaturation leads to single strands, which are (6) amplified to create millions of clusters
of identical copies of each DNA template (diameter of 1 µm or less). (7) Now sequencing can
start by addition of all four dNTPs, each labeled with a different fluorochrome, as well as
primers and DNA polymerase. In each sequencing cycle, one kind of dNTP is incorporated per
cluster. (8) Since the fluorescence marker serves as a terminator for further polymerization,
the emitted fluorescence from each cluster, revealing the kind of dNTP incorporated, can now
be identified by laser excitation. (9) The reversible terminators are enzymatically cleaved
and the sequencing cycle is repeated multiple times to determine the whole sequences.
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hundred individual phage clones [9]. Around the turn of the millenium the Human Genome
Project stimulated the development of fast and low cost high throughput sequencing
technologies - the era of next-generation sequencing (NGS), also called deep-sequencing,
had started [107]. One of the leading companies for NGS is Illumina. It offers the highest
throughput (more than 107 reads can be analyzed in a single run [9]), as well as the
lowest per-base cost, and a read length of up to 300 bp, which is sufficient for most
applications [107, 108]. Using paired-end sequencing, forward and reverse reads of each
fragment are produced, thus improving data accuracy [109].
The Illumina sequencing technology is based on the formation of template clusters and
the subsequent four-colour cyclic reversible termination method. Fig. 2.12 illustrates
the sequencing process. Initially, the DNA fragments have to be linked to adpaters
(1) [105]. In a phage display context, the DNA inserts of interest are amplified by PCR,
and adapters as well as barcodes to identify each fragment are attached via the PCR
primers [9]. Solid-phase amplification is then used to create clusters of identical copies of
each DNA template (2-6). Sequencing is subsequently performed by the incorporation of
one kind of fluorescently labeled dNTP per cluster. This terminates the polymerization
and the fluorescence signal can be read out by laser excitation to identify the base. After
removal of the fluorescent dye, the next sequencing cycle can start [105].
With NGS it is possible to characterize large sequence collections. In a phage display
context it improves the chance of selecting phages with binding affinity to a certain
target. The entire phage pool can be analyzed after the last biopanning round, or
even after every round, providing the complete sequence spectrum. Sanger sequencing
preferably identifies high abundant clones, but there is a considerable risk that these
clones are target-unrelated ones, either unspecifically binding or propagation-related [96,
110]. With NGS also less enriched phage clones are identified for certain, and changes
in copy numbers of clones can be observed from round to round. One disadvantage of
NGS compared to Sanger sequencing is that enriched sequences are easily identified, but
corresponding phage clones are physically unavailable. This problem might be overcome
by an inverse PCR-based method to isolate phage clones of interest after NGS [111], or
by synthesizing the corresponding peptides and using them instead of phage clones.
2.5 Phage applications - phage display and beyond
Since they are robust and harmless to humans, cheap in production without the need of
killing animals, and easily genetically engineered or modified, bacteriophages have become
of great interest not only as a tool for the identification of novel affinity reagents for
diagnostics, but also for many other applications [99]. Phage display can be used to study
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protein-protein interactions and enzyme specificities, as well as to map epitopes of antigens
involved in antibody binding [81]. It allows the detection of potential cellular targets of
small molecules as therapeutics for medicine and in the context of risk assessment for
environmental and human health [112]. Phages displaying ligands for cell surface receptors
can be used for gene and drug delivery and as imaging agents for tumour targeting [86,
113–115].
Whole phages can be used as capturing and recognition elements for biosensors and
bioassays, reaching from classical tests based on enzymes, colorimetry, or fluorescence,
up to surface plasmon resonance, surface-enhanced Raman spectroscopy, as well as
electrochemical-based, and piezoelectric or magnetoelastic mass-based assays [99].
Combination with nanotechnology enabled the development of phage-derived nano-
materials. Several phage peptides which bind to inorganic materials were identified,
including metals, semiconductor materials, and carbon nanotubes [80]. Phages can now
also serve as a building block for the formation of nanoscale structures like nanowires [116–
118], nanofibers [119], or conducting nanocomposites [120]. Phages binding to zinc
sulfide nanocrystals align to ordered nanocrystal films in the presence of zinc sulfide
precursors [121]. Multifunctional phages, able to nucleate amorphous iron phosphate,
and with binding affinity to single-walled carbon nanotubes, were used to fabricate high
power lithium-ion batteries [122].
Phage therapy represents a very different, but also promising field of application for
phages in general. Bacteriophages have been used as therapeutic agents for long time,
and actually were discovered in this context (see 2.3.1). Since phages kill their bacterial
host, they can serve as an alternative to antibiotics. They are highly specific and could
be used against antibiotic resistant strains [78].
2.5.1 Phage functionalisation
Genetic manipulation of phages in a phage display context has led to a huge variety of
applications. Moreover, phages can also be used as a scaffold for chemical modifications,
opening an even wider field of functionalities. Synthetic molecules can be attached to the
phage coat proteins using bioconjugation techniques. Options include the non-specific
modification of the free amino groups of lysine residues, the phenol groups of tyrosine
residues, or the carboxylic acid groups of aspartate and glutamate residues [123]. Phages
can thus be labeled with small organic molecules like carboxylic acid groups [118], with
fluorochromes [115, 124–127], or drugs [128, 129]. In most cases phage display and
functionalisation are combined in one approach, so phages are dual-modified for instance
with cancer cell targeting motifs and fluorescent dyes [124], or with bacteria targeting
motifs and cytotoxic drugs [128].
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2.5.2 Phage-based microarray
Microarray technology is a high-throughput method based on biomolecules immobilized
in an array format on a solid platform (typically planar glass slides). In most cases these
biomolecules are oligonucleotides, PCR products, proteins, peptides, or carbohydrates.
The array is then probed with a sample to detect molecular recognition events [10]. Protein
microarrays represent miniaturized immunoassays, with lower sample consumption and a
higher sensitivity due to the improved signal-to-noise ratio [130]. They can be classified
Figure 2.13: Protein microarray experiment. An array of capturing molecules is blocked to
limit unspecific binding and probed with the sample to identify interacting biomolecules.
Binding events can either be detected directly using label-free methods like mass spectrometry
(MS), surface plasmon resonance (SPR), atomic force microscopy (AFM), or quartz crystal
microbalance (QCM), or by using a labeled probe [10].
into three different types [131]. Analytical arrays are based on an array of capturing
molecules (antigens, aptamers, antibodies) with known identity to analyse a biological
sample, searching for interacting components like antibodies or proteins. Applications
include clinical diagnostics and differential expression profiles [131]. In contrast to this,
individually purified, functional proteins are spotted on the surface to study the interaction
of these proteins with another biomolecule in functional microarrays [132]. For reverse
phase microarrays a complex sample is immobilized in an array format and probed with
antibodies against the protein of interest [130].
In most cases binding events are optically visualized by direct fluorescence labeling of
the interacting partner, or in a sandwich format, using a secondary labeled antibody
[130]. Nevertheless, label-free detection methods were also developed, including mass
spectrometry, surface plasmon resonance, micro-electromechanical systems cantilevers
and others [10].
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To date, three works have been presented which combine phage display and microarray
technology. Arnaud et al. produced an array of phage-displayed, HIV-epitope mimicking
peptides on a nitrocellulose membrane to monitor the antibody binding and thereby the
immune response of four patients prior to and after antiviral therapy [133]. A similar
approach was successfully used to study the immune response in cancer patients [134].
Here, phages were spotted on gamma aminopropyl silane slides.
Whereas these two works studied phage display systems based on pIII, Vaglenov developed
a phage-based microarray using pVIII-displaying phages [135].

3 Materials and Methods
3.1 Materials
This section briefly introduces bacteria, phages and phagemids relevant for biopanning as
well as the norovirus like particles as target molecules. More background information can
be found in the fundamentals part. All additional material is listed in the supplementary
part, including chemicals as well as information to buffers, media, enzymes, antibodies,
antibiotics, primers, and peptides relevant for the experiments.
3.1.1 Microbiological material
Bacteria
E. coli TG1λ was employed as bacterial host for phages and phagemids. It originates
from E. coli K12 TG1 with the genotype F’ [traD36 proAB+ lacIq lacZ∆M15]supE thi-1
∆(lac-proAB) ∆(mcrB-hsdSM)5, (rK-mK-). Important for phage display is the presence
of the F’ episome, containing the information for the F pilus essential for phage infection.
TG1λ is a lysogen genotype produced by the Fraunhofer Institute for Celltherapy and
Immunology, Leipzig, containing the λ-phage as a prophage. The expressed λ-repressor
does not only inhibit cell lysis, but also represses the phagemid promoter to minimize
the expression of the gene III fusion protein inside the bacterial cells [136].
E. coli ER2738 (New England Biolabs, Germany) were used to amplify M13KE phages
for phage ELISA and array experiments, see [98] for further information.
Phagemid library
The library employed in this thesis was the ENTE1 library based on the pPepPr3A
plasmid. It contains the information for the foreign peptide sequence (Entechon peptide
sequence) linked to the pIII gene, as well as the beta lactamase gene for ampicillin
resistance.
The ENTE1 library has a complexity of more than 109 different peptide sequences. One
displayed sequence consists of 16 amino acids. All natural amino acids are equally
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Figure 3.1: Plasmid map of pPepPr3A (unpublished data by M. Szardenings and N. Delaroque).
The phagemid has a bacterial and a phage origin of replication, a beta lactamase gene for
ampicillin resistance, and the information for a signal peptide (ompA leader), directly followed
by the ENTE1 peptide sequence and gene III.
distributed, but without stop codons. Only methionine and tryptophane are underrepre-
sented, and cysteine is not allowed on all positions to avoid disulfide bridges inside the
sequence. A cysteine or serine is on the fourth position of each sequence.
Bacteriophages
Bacteria carrying the phagemid have to be superinfected by helper phages to produce
phages displaying the foreign peptide sequence. Here, M13K07 helper phages were used.
They are a M13 derivative with a kanamycin resistance gene inserted within the M13
origin of replication [137].
For phage ELISA and array experiments, M13KE phages (New England Biolabs, Germany)
were used. M13KE is a derivative of the common cloning vector M13mp19, and was
amplified in the E. coli ER2738 host strain.
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3.1.2 Norovirus like particles
Norovirus like particles (NoVLPs) were kindly provided by Riboxx GmbH, Radebeul,
Germany, dissolved in 10 mM bicin and 150 mM sodium chloride in 50 % glycerol (pH 9).
Prior to delivery, Riboxx GmbH had checked purity and size by SDS polyacrylamide gel
electrophoresis, and protein concentration had been determined by bicinchoninic acid
(BCA) protein assay.
NoVLPs are composed of VP1 norovirus capsid proteins. These proteins are able to self
assemble to virus like particles. In nature, the norovirus consist of 180 copies of the VP1
protein and 1 to 2 copies of the VP2 protein. Since VP2 is not important for capsid
structure, for the VLPs it is negligible.
Unless otherwise stated, NoVLPs of genotype II.4 cluster Grimsby (NV II.4 Grimsby
VP1) were used. Here the VP1 has the consensus sequence of different VP1 proteins of
the cluster Grimsby, with an additional 6x histidin-tag (see Supplemental Materials A.2).
3.2 Phage display related methods
For each biopanning selection approach various phage display related methods are
required, reaching from basic techniques like bacteria cultivation and determination of
phage concentration to specific ones like cosmix-plexing R©. Since the focus of this thesis
was on the chromatographic biopanning, all methods relevant for this strategy will be
described in more detail here.
3.2.1 Bacteria cultivation and optical density measurement
Bacteria TG1λ were cultivated in dYT medium. Ampicillin was added if necessary. For
liquid cultures, up to 25 ml of culture were grown in 250 ml conical flasks at 120 rpm,
37 ◦C. For larger volumes, bigger flasks were used accordingly. For short term storage,
bacteria were streaked on M9 agar plates, incubated overnight at 37 ◦C, and stored at
4 ◦C for not longer than a week. For long term storage, a freshly grown overnight culture
was diluted in glycerole (50%/50%) and stored at - 80◦C.
Cell density of liquid cultures was determined by optical density (O.D.) measurement
at 600 nm using a photometer (Eppendorf, Germany), and dYT medium was used as
reference.
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3.2.2 Biopanning based on column chromatography
Biopanning selection was based on chromatographic separation (see chapter 2.4.2). For
ion exchange chromatography, a cation exchange column, the CIM R© SO3 disk monolithic
column (BIAseparations, Slovenia), was used. For affinity chromatography, a HiTrap
IMAC column (GE Healthcare, Germany) charged with Nickel ions for immobilized metal
ion affinity chromatography (IMAC) was applied to bind the 6x histidin-tagged NoVLPs.
In Table 3.1 the columns are described in more detail.
Table 3.1: Chromatography column characterization
Column CIM R© SO3 disk monolithic
column
HiTrap IMAC FF column
separation
method
cation exchange chromatography immobilized metal ion affinity
chromatography (IMAC)
disk chemistry strong cation exchanger
(sulfonyl)
chelating groups charged with
Ni2+
support matrix CIM R© methacrylate-based
porous polymer matrix
IMAC Sepharose 6 Fast Flow
(agarose beads with covalently
immobilized chelating groups)
column volume 1 ml/2 ml 1 ml
operating flow
rates
2-4 ml/min 1 ml
The columns were attached to an ÄKTA
TM
avant chromatographical system (GE Health-
care, Sweden), which is operated by the UNICORN 6 software. UNICORN is a software
package for controlling the chromatography system and evaluating the separation runs.
Parameters for all chromatograhy steps, including equilibration, sample application,
column wash, elution and re-equilibration, were defined using the UNICORN Method
Editor. The schematic flow path is shown in Fig. 3.2.
The BufferPro tool of UNICORN was used to automatically prepare the buffers and to set
the pH during a run based on four stock solutions, that can be mixed by a quarternary
valve (Q1 - Q4), as shown in Tab. 3.2. 0.2 M Na2HPO4 and 0.2 M NaH2PO4 were freshly
prepared for each biopanning round and sterile filtered before use.
The sample was applied using a syringe to fill a sample loop of the appropriate size (e.g.
1 ml loop for 1 ml sample volume). After equilibration of the system with binding buffer,
the sample from the sample loop was injected using an injection valve. The sample was
then directed to the chromatographic column, followed by intense washing of the column
(20 - 25 ml). Molecules able to bind to the column matrix remained, and and all-non
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Figure 3.2: Schematic flow path for a chromatography system [102]
Table 3.2: Input solutions for chromatographic buffer preparation
Pump Buffer/Solution
Q1 0.2 M Na2HPO4
Q2 0.2 M NaH2PO4
Q3 H2O
Q4 4 M NaCl
binding molecules passed through. System pressure was monitored during the run to
ensure that the pressure limits of the column were not exceeded.
Inline detectors measuring UV/Vis absorbance at variable wavelengths and conductivity
were used to monitor the chromatographic process. At 214 nm peptide bonds absorb light,
at 260 nm DNA/RNA is detected, and absorbance measurement at 280 nm will provide
information about aromatic amino acid residues [102]. UV absorbance will therefore
give information about the eluted proteins and the total protein content. Here, 220 and
280 nm were used to detect NoVLPs (only protein), whereas 270 nm was used as an
indicator for bacteriophages (protein +DNA).
The conductivity monitor shows changes in salt concentration during the run. During
equilibration, the signal should get stabilized to show that the column is equilibrated,
during sample application and washing salt peaks can be detected, and during elution,
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the formation of the salt gradient is monitored. In contrast to Fig. 3.2, pH was not
detected during biopanning runs.
NoVLPs (with bound phages) were eluted by increasing NaCl concentration for ion
exchange chromatography, and by 500 mM imidazole (manual injection) for affinity
chromatography. To collect eluted samples, a built-in fraction collector was used. Fraction
volumes were 1.5 ml and 0.5 ml for CIM R© SO3 and HiTrap IMAC column, respectively.
Prior to and after each chromatographic run, the ÄKTA
TM
avant chromatographical
system was washed with 1 M NaOH, and blank runs in binding buffer were performed
until no peak was observable in the chromatogram.
3.2.3 Infection of bacteria with phages
10 ml of exponentially growing bacteria (O.D. of 0.5 - 1.0), shaking for at least 30 min at
37 ◦C, were infected with the eluted phages and incubated at 37 ◦C and 120 rpm. After 15
to 30 min the bacteria were poured on a freshly prepared 25x25 cm dYT agar plate with
0.2 mg/ml ampicillin, spread out, dried under sterile conditions and incubated overnight
at 30 ◦C. A small aliquot of the liquid culture was withheld for determination of the
absolute number of eluted phages, see section 3.2.6.
3.2.4 Packaging of phagemid DNA in phage particles
Next day, the 25x25 cm plate was washed on a slow rocker with 25 ml dYT medium
supplemented with 1010 M13K07 helper phages per ml. After 10 to 15 min, the supernatant
containing portions of all bacteria colonies was recovered from the plate and used for
three different purposes.
For phage production, a volume of bacteria suspension resulting in an O.D. of maximal
0.5 was added to 25 ml of prewarmed dYT medium with 0.5 mg/ml ampicillin and 1010
M13K07 helper phages per ml. For infection and reinfection of helper phages, the culture
was incubated at 37 ◦C and 120 rpm for at least 45 min. Subsequently, phages were
amplified overnight for maximal 13 hours at 30 ◦C and 120 rpm.
In addition, clones recovered from the plate were prepared for long term storage, and, after
the second round of biopanning, for cosmix-plexing R©. For storage, 2 x 1 ml were diluted
in glycerole (50%/50%) and stored at - 80◦C. For cosmix-plexing R©, a bacteria culture
was started with an O.D. of maximal 0.1 in 200 ml dYT with 0.25 mg/ml ampicillin, and
incubated overnight at 30 ◦C and 120 rpm. Plasmid DNA was prepared as described in
section 3.4.1.
For all other biopanning rounds, the remaining cells were centrifuged for 30 min and
4600 rpm at 4 ◦C. The supernatant was discarded and the pellet stored at -20 ◦C.
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3.2.5 Purification of phages
Overnight cultures were centrifuged for 15 min at 14000 rpm and 4 ◦C. 20 ml of the
supernatant was mixed with 5 ml PEG/NaCl and incubated on ice for at least 1 hour.
The precipitated phages were pelleted by 30 min centrifugation at 14000 rpm and 4 ◦C
and resuspended in 1 ml PBS. To remove insoluble substances the phage suspension was
centrifugated again for 20 min at 14000 rpm and 4 ◦C. The supernatant was mixed with
250µl PEG/NaCl and incubated on ice for 30 min. Again, the precipitated phages were
collected by 30 min centrifugation at 14000 rpm and 4 ◦C. The remaining phage pellet was
resuspended in 200µl PBS and recentrifuged as above to remove insoluble substances.
The supernatant was transferred to a fresh tube and the purified phage suspension was
stored at 4 ◦C.
3.2.6 Determination of phage concentration
To determine the phage titer a dilution series was prepared in a 96 well plate. 10µl of
the phage suspension were mixed with 90µl dYT medium in a well and diluted further
1:10 up to a 10−10 dilution.
10µl of each dilution (10−7 to 10−10) were mixed with 90µl of an exponentially growing
bacteria culture (O.D. 0.5 to 0.7) and incubated for 45 min at 37 ◦C to allow infection.
Finally, 3µl of each sample were pipetted on a dYT agar plate in triplicates and incubated
overnight at 30 ◦C.
To determine the absolute phage number obtained in a biopanning round, a dilution series
up to 10−3 was prepared starting with 100µl culture and 900µl dYT medium. Here,
100µl of each dilution were spread out on a dYT agar plate and incubated overnight
at 30 ◦C. Next day, colony forming units (cfu) were counted and the original phage
concentration was calculated.
3.2.7 Recombination of sequences by cosmix-plexing R©
Sequences can be recombined by Cosmix-plexing R© as explained in section 2.4.1.
Cosmix-plexing R©
For cosmix-plexing R©, the enriched phagemid DNA after the second round of biopanning
was amplified as described in section 3.2.4. Next day, plasmid DNA was prepared in a
midi prep (see section 3.4.1) and DNA concentration was determined (3.4.2).
Plasmid DNA was restricted in the hypervariable region by BpmI for 4 hours at 37 ◦C
using an enzyme concentration of 0.5 units per µg DNA. The sample was incubated
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at 65 ◦C for 20 min to inactivate the enzyme. To generate concatemers the restricted
DNA (570 ng/µl) was ligated by T4 Ligase (1 unit per µg DNA) for 75 min at 16 ◦C. The
enzyme was inactivated at 65 ◦C for 10 min. Concatemers were restricted to produce linear
plasmid fragments by BglI for 2 hours at 37 ◦C with a subsequent enzyme inactivation step
at 65 ◦C for 20 min. Enzyme concentration was 1 unit per µg DNA. For recircularisation,
low concentrated DNA fragments (12.5 ng/µl) were incubated overnight at appr. 8 ◦C
with T4 Ligase (4 units per µg DNA). The enzyme was inactivated at 65 ◦C for 20 min.
Restriction and ligation steps were optimized in terms of duration and enzyme concentra-
tion and each intermediate step was checked by gel electrophoresis. The recircularised
plasmids were purified by a phenol-chloroform extraction and subsequent ethanol precipi-
tation.
Transformation
The ability of bacterial cells to be transformed, i.e. to take up exogenous, naked DNA, is
called competence. In addition to natural competent cells, this state can be induced. One
possibility is the electroporation: the permeability of the cell membrane is increased due
to an external electrical field. Electrocompetent bacteria were prepared as follows: 5 ml
of an overnight TGIλ culture were grown in 250 ml dYT in 2 L conical flasks in 4 parallel
cultures. Reaching an O.D. of 0.7, the cultures were cooled down in an iced water bath
for 30 min and centrifuged for 20 min at 4000 g and 4 ◦C. Cell pellets were resuspended in
300 ml icy aqua dest. by shaking. Centrifugation and resuspension were repeated three
times. After the last centrifugation, cells were resuspended in 20 ml icy 10% glycerol and
centrifuged again at 4600 g and 4 ◦C for 25 min. Finally, cells were resuspended in 400µl
icy 10% glycerol, all four reactions were merged and the O.D. was determined to check
that at least 1×1011 cells were available for transformation.
80µl of freshly prepared electrocompetent cells were added to 1µl of plasmid DNA in
an icecold electroporation cuvette with an electrode gap of 1 mm (peqlab, Germany).
Pulse for transformation was set by a Gene Pulser Electroporation System (Bio-Rad
Laboratories, USA). Parameters for electroporation were a voltage of 1800 V, a capacity
of 25µF, and a resistance of 200 Ω. Immediately after transformation 1 ml of prewarmed
medium was added and bacteria were collected in one flask. After 18 (A6_R2) and 15
(A7_R2) successful transformations, respectively, bacteria were used up and medium was
refilled to 50 ml.
Preparation of recombined library
Transformed cells were incubated for 1 h at 37 ◦C, 150 rpm to express the antibiotic
resistance. Subsequently, an aliquot of 100µl was used for the dilution series to determine
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the phage concentration, and all other bacteria were poured on 10 25x25 cm dYT agar
plates with 0.2 mg/ml ampicillin, spread out, dried under sterile conditions and incubated
overnight at 30 ◦C. Next day, phagemid DNA was packed into phage particles (total
volume of 200 ml) as described in section 3.2.4. Phages were purified (final volume 600µl)
and phage concentration was determined.
3.3 Enzyme linked immunsorbent assay (ELISA)
Enzyme linked immunosorbent assays (ELISAs) are immunoassays to study the interaction
of antigens and antibodies. In the simplest format, the antigen is immobilised on a solid
phase. The bound antibody is detected by a secondary antibody, directed against the
first one and labeled with a reporter enzyme, in this case horseradish peroxidase (HRP).
By adding the substrate of the enzyme, the enzymatic reaction can be quantified, e.g. by
colour change due to the reaction product.
ELISA experiments were performed in Nunc MaxiSorp R© flat-bottom 96-well plates. First,
wells were coated overnight with 50µl of antigen in ELISA coating buffer (see A.1). Next
day, wells were washed three times with wash buffer (200µl per well), and blocked with
100µl blocking buffer for 1 h. Subsequently, wells were washed six times and incubated
with 50µl of primary antibody, and afterwards with HRP-labeled secondary antibody,
each time for 90 min, and with 6 washing steps afterwards. Antibodies were diluted in
blocking buffer. In peptide ELISAs, biotinylated peptides were used instead of primary
antibodies, and streptavidin coupled to HRP (streptavidin-HRP) was added as secondary
antibody, taking advantage of the strong interaction between biotin and streptavidin.
Then, 100 µl of 3,3’,5,5’-tetramethylbenzidine (TMB) substrate solution was added
to each well for 15 min, followed by 100 µl TMB stop solution (0.18 M H2SO4) to
terminate the enzymatic reaction. Absorption was measured using an Infinite R© M200
PRO spectrophotometer (TECAN, Switzerland) at a wavelength of 450 nm, with a
reference wavelength of 590 nm. Data are presented as arithmetic means + standard
deviation using the Origin software.
3.4 Molecular biological methods
3.4.1 Isolation and purification of DNA
Plasmid DNA was isolated and purified at midiprep scale using the NucleoBond R© Xtra
Midi Plasmid DNA purification kit (Machery-Nagel, Germany). For plasmid DNA
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preparation at miniprep scale, the QIAprep R© Spin Miniprep Kit (Qiagen, Germany) was
used. PCR products were purified using the QIAquick R© PCR purification kit (Qiagen,
Germany). DNA was reconstituted in 80µl (Midiprep), 40µl (Miniprep), or 30µl (PCR
purification) of 10 mM Tris-Cl, pH 8.5.
3.4.2 Determination of DNA concentration
DNA concentration was determined by a NanoDrop
TM
ND-2000 instrument (Thermo
Fisher Scientific, USA) according to the manufacturer indication, using 2µl of DNA.
3.4.3 Agarose gel electrophoresis
Plasmid DNA and PCR products were analysed on horizontal agarose gels (0,8 %). 0.4 g
agarose was dissolved in 50 ml TAE buffer by heating, and allowed to slightly cool down
before adding 1.5µl ethidium bromide (0.5µg/ml) and pouring the gel into a gel chamber
for polymerization. Samples (mixed with 6x Orange DNA loading dye, Thermo Scientific,
2 µl to 10µl of sample), and marker (GeneRuler 1 kb Plus DNA Ladder, Thermo Scientific,
5µl) were loaded onto the gel. Gel electrophoresis was performed at 100 V and bands
were visualized by an UV transilluminator. GIMP 2.8.16 software was used to insert
labels into the images.
3.4.4 Next-generation sequencing
Sample preparation
A polymerase chain reaction (PCR) was performed prior to sequencing to amplify the
plasmid region of interest of the phage pools and to add the necessary bar codes for
next-generation sequencing. PCR reactions were conducted as follows:
Table 3.3: PCR reaction
Reagent Volume
10x Pfu buffer (with MgSO4) 5µl
dNTPs (10 mM each) 1 µl
Forward primer (10 pmol/µl) 1µl
Reverse primer (10 pmol/µl) 1 µl
Pfu polymerase 0,5µl
Phages/DNA 4×107 phages in 5µl or 15 ng DNA in 1µl
H2O to 50µl
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Table 3.4: PCR program
Temperature Duration
95.0 ◦C 5 min
95.0 ◦C 45 s
12x 61.6 ◦C 45 s
72.0 ◦C 15 s
4.0 ◦C break
A negative control without DNA/phages was carried along. For each sample, 6 reactions
were merged after PCR to get a total volume of 300µl. Quality was checked by agarose
gel electrophoresis (see section 3.4.3). PCR products were purified using the QIAquick
PCR purification kit (Qiagen, Germany), according to the manufacturer instructions.
DNA was eluted in 30µl elution buffer and concentration was determined (see 3.4.2).
Final NGS samples were stored at -20 ◦C. Sequencing was performed by LGC Genomics
GmbH, Berlin (Pools A6_R2, A7_R2, PA6_R3, and PA7_R3), or by the team of the
Ligand Development Unit, Fraunhofer Institute for Cell Therapy and Immunology in
Leipzig (Pools NP and PA6_R3+NP), using a MiSeq
TM
system (Illumina, USA).
NGS data analysis
A new software for sequence data evaluation, named LibDB, was developed by PolyQuant
GmbH, Bad Abbach, and the Ligand Development Unit, Fraunhofer Institute for Cell
Therapy and Immunology, Leipzig. Data of a sequence run were imported, and based on
the provided patterns of the naive libraries, each sequence of a run was automatically
checked for validity. Sequences not matching the intended structure of the library were
sorted out (invalid sequences).
LibDB generates an analysis page for each run. It contains an overview table, showing
the number of total and valid sequences, the used library pattern and the number of
found motifs (three amino acids: 3-mer, four amino acids: 4-mer). The analysis page
also contains a link to the frequency table page. Here, firstly a histogram lists how many
sequences can be assigned to a certain number of occurrences. In the second part of
the page, the top 100 sequences are listed. Finally, in a complete frequency table total
numbers of occurrences for each amino acid at a certain position of the variable region
are shown.
The most important features of the LibDB software are the analysis of motifs and motif
neighbourhoods. For each motif it calculates the occurred frequency as a logarithmic
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representation as described in equation (3.1) (with N as the number of locations in which
the motif can be found in the 16 bp randomized sequence - 14 x for a 3mer, 13 x for a
4mer motif). Based on the theoretically expected frequency, the enrichment is determined
as the difference between occurred and expected frequency (equation (3.2)).
relative frequency = −log
(
total count of motif
total count of valid sequences ∗ N
)
(3.1)
enrichment = theoretically expected frequency − occourred relative frequency (3.2)
All motifs are listed in a table and can be arranged in alphabetical order, or according to
the total number of counts, their occurred or expected frequency, or their enrichment. A
particular motif can also be searched directly (allowing variables).
Each motif can be individually selected to list all sequences containing it. They can
be exported as fasta data for further analysis and alignment. Additionally, the motif
neighbourhood can be analysed. A pattern for analysis has to be chosen: e.g. AXMMMXB
will analyse the second amino acid before and after the 3-mer motif. Counting strategy
can be either only unique sequences, or all sequences (allowing duplicates). Motifs
overlapping with constant regions are excluded. As result, a frequency table is produced,
showing the amino acid distribution for A (x axis) and B (y axis). To compare different
runs, these data were exported to Microsoft Office Excel.
3.5 Phage-based microarray related methods
3.5.1 Labeling of phages
Phages can be directly labeled by fluorescent dyes at the pVIII major coat protein without
loosing their binding characteristics [126]. Therefore, fluorescein isothiocyanate (FITC)
was freshly dissolved in dimethyl sulfoxide (DMSO) at a concentration of 5 mg/ml. Phages
M13KE were diluted to 4×1012 pfu/ml in a total volume of 100µl and precipitated by
adding 17µl of PEG/NaCl and incubating on ice for 1 hour. Phages were then centrifuged
for 10 min at 14000 rpm and 4 ◦C and the pellet was resuspended in 100µl conjugation
buffer (Na2CO3 0.1 M / NaHCO3 0.1 M pH 9.0). 5µl of the FITC solution were added
and the conjugation was performed overnight at 4 ◦C in the dark. Next day, unbound
FITC was removed by precipitating the phages twice as described above. The labeled
phages were resuspended in PBS.
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3.5.2 Surface functionalisation for phage arrays
A solid support surface is needed for microarray fabrication. Here, 22x22 mm or 22x50 mm
glass coverslips (thickness 1.5) were used. They were cleaned with acetone in an ultrasonic
bath for 5 min and immediately rinsed with isopropanol. After organic solvent cleaning,
glass slides were incubated in bidistilled water in an ultrasonic bath for 5 min. Finally,
they were rinsed with bidistilled water and dried under nitrogen blow. Immediately
before functionalisation, glass slides were plasma cleaned for 2 min (Plasma-Prep
TM
II
Plasma Etcher, SPI Supplies, USA), to generate reactive hydroxy groups (Si-OH).
The organosilane 3-aminopropyldimethylethoxysilane (APDMES) was chosen for covalent
functionalisation of glass slides. It provides positively charged aminogroups which can
bind to the negatively charged phage surface. APDMES was attached in gas phase by
incubating the glass coverslips with 50 µl APDMES in a glass petri dish at 70 ◦C for
15 min. To crosslink the organosilane, a postbaking step was performed at 120 ◦C for
20 min.
3.5.3 Non-contact printing of phages
To create protein microrarrays, samples are printed and immobilized on a solid support
surface in a pre-defined pattern. Here, the Nano-Plotter
TM
micropipetting system (GeSiM
mbh, Germany) was applied to array the phage suspensions on a prepared glass surface.
Samples were printed in a non-contact mode by a piezoelectric pipetting tip, the pico-tip.
This micropipette produces droplets of around 70 - 80 pl, resulting in spot sizes of 80 µm
in diameter and larger. The actual spot diameter is dependent on the contact angle of
the droplet on the particular surface.
The Nano-Plotter
TM
was operated by the NPC16 software (version 2.15.46). To fabricate
an array, parameters were defined in the work plate settings. Spot-to-spot distance was
set to 200 µm for phage arrays on APDMES functionalised glass slides and to 250 µm for
arrays on freshly Plasma cleaned surfaces. The array layout was defined in a transfer list.
Fig. 3.3 represents typical layouts for testing 3 different phage concentrations in one array.
In preparation for printing, 30 µl of samples were filled into a 384 microtiter well plate.
Phage M13KE suspensions were diluted in PBS and 1 mg/ml BSA in PBS was used as a
negative control. Humidity was set to 70 %. Each pipetting cycle consisted of sample
aspiration from the well plate, optimizing the dispense parameters by video (stroboscope),
spotting and finally emptying, washing and drying of the pipette. Successfully printed
phage arrays were used immediately or stored at 4 ◦C in an N2 atmosphere.
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Figure 3.3: Typical spot layout for printing 3 different phage concentrations (green spots)
and BSA negative controls (grey spots) for A) static phage array (1: 2.5×1011 phages/ml,
2: 1×1012 phages/ml, 3: 4×1012 phages/ml), and B) phage array with integrated microfluidics
(1: 1×1012 phages/ml, 2: 5×1011 phages/ml, 3: 2.5×1011 phages/ml).
3.5.4 Hybridisation
Prior to hybridisation, the printed array was encircled by a liquid blocker pen (Super
PAP Pen Liquid Blocker Mini, Science Services, Germany). The array was then blocked
with 1 mg/ml BSA in PBS for 30 min and the whole glass coverslip was washed once with
PBS + 0.05 % Tween-20 in a small box for 1 min. Primary mouse anti-pVIII antibody
was diluted in blocking buffer and hybridisation was performed for 30 min. The slide
was washed three times as mentioned above to remove unbound antibody and incubated
with secondary DyLight
TM
488 - goat anti-mouse antibody in blocking buffer for 30 min.
Afterwards, the glass slide was washed again three times and carefully dried before
microscopy.
3.5.5 Fluorescence microscopy
For fluorescence microscopy the inverted Axiovert 200 microscope (Zeiss, Germany)
was used in combination with the HBO illuminating system (Zeiss, Germany) and
the Uniblitz R© VMM-D1 shutter (Vincent Associates R©, USA). Fluorescent phage array
images were studied using the 10x objective and the filter set 10 (Zeiss, Germany),
corresponding to an excitation wavelength of 450 - 490 nm and an emission wavelength of
515 - 565 nm. Images were acquired by the Photometrics cascade R© 512B camera (Roper
Scientific, Germany) using MetaVue
TM
Research Imaging Software (Molecular Devices,
USA). Microscope and software settings were kept constant for all measurements. Unless
otherwise indicated, exposure time was set to 300 ms, and two images were taken for
each phage concentration/antibody combination.
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3.5.6 Image analysis
8-bit copies of all images were analysed using the software ImageJ 1.46r. The plugin
Microarray Profile was used to analyse a grid of 2 × 2 spots of each image as well as the
background in the center of the grid. Diameter of the circles to analyse was adjusted
to the diameter of the spots, and subsequently the mean grey value of 4 spots as well
as of the background was measured for signal-to-background calculation. For image
presentation, grey values were changed to the original FITC colour values (minimum:
green/red/blue = 0, maximum: green = 255, red = 146, blue = 0) using the Color
Channels Tool, and images were adjusted using the contrast option. For fluorescence
intensity analysis, data are presented as arithmetic means ± standard deviation using
the Origin software.
3.5.7 Integration to microfluidics
A microfluidic channel was prepared by soft lithography, using an elastic stamp made
of polydimethylsiloxane (PDMS). Therefore, components A and B of the Sylgard 184
elastomer kit were mixed 6:1 and degassed for 20 min. The still liquid PDMS was
then poured over a stripe-like master channel on a Si wafer and left on a hot plate
for polymerisation. Subsequently, the PDMS block containing the channel was cut out
and pierced by a biopsy needle to generate an inlet and an outlet for the channel. The
Nano-Plotter
TM
was prepared, and directly before spotting the glass slide was cleaned and
plasma treated for 2 min. Parallel to the printing process, the PDMS channel was also
plasma treated for 4 min to minimize the time between plasma activation and alignment.
Alignment was performed by gently placing the channel onto the block of spots without
any pressure. Now, plasma-disrupted surface silicon-oxygen bonds can be reformed
between glass slide and PDMS, resulting in a permanent connection. Tubes for inlet and
outlet were fixated in the provided holes, again by PDMS. Blocking with 1 mg/ml BSA
was performed offline by inserting the blocking solution manually with a glass syringe
(SGE Analytical Science, Australia). All further steps were done online using a neMESYS
syringe pump and the associated neMESYS UserInterface software (CETONI, Germany).
Three glass syringes were connected to the channel using a 4-way intersection. They
contained wash puffer (PBS + 0.05 % Tween-20), anti-pVIII antibody (1:200 in blocking
buffer), or secondary antibody (1:1000 in blocking buffer), respectively. Flow velocity
was set to 1 ml/hour. Staining protocol included the following steps:
1. wash buffer 250 µl
2. anti-pVIII antibody 250 µl
3. wash buffer 250 µl
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4. secondary antibody 350 µl
5. wash buffer 350 µl
The microfluidic channel was monitored and images were acquired using fluorescence
microscopy as described above. Signal-to-background ratio was calculated by measuring
2 spots each time in 2 different channel areas, as well as the background as described
above.
3.6 High resolution microscopy methods
3.6.1 Atomic force microscopy
Atomic force microscopy (AFM), a scanning probe microscopy technique, was used for
visualization of NoVLPs and bacteriophages. With AFM it is possible to determine
the three-dimensional profile of a sample surface on the nanoscale by detecting the
forces between the surface and a tip, which is placed on the end of a flexible cantilever.
These forces lead to a deflection of the cantilever which can be monitored using the
reflection of a laser beam and a position sensitive photo detector. A feedback control
keeps the tip-sample distance on a consistent value. By recording the feedback signal,
the topography of the surface can be measured [138].
Samples were prepared on freshly cleaned silicon dioxide, functionalised with APDMES
(see 3.5.2) for NoVLPs, and functionalised with APTES (3-aminopropyltriethoxysilane)
or nonfunctionalised for bacteriophages, respectively. 5 µl of NoVLPs (190 µg/ml) in
PBS or 1.5×108 phages in 5 µl of TBS were incubated for 2 min on the surface, washed
with 10 µl of deionized water and carefully dried by nitrogen blow. Measurements
were performed in dry conditions using the atomic force microscope NanoScope R© IIIa
MultiMode (Veeco, USA) in a dynamic mode (tapping mode) and antimony doped silicon
tips (Veeco, USA, and Bruker, Germany, respectively). Resonance frequency was set by
auto tuning. Surfaces were scanned with a scan rate of 1 Hz. The functions integral gain,
proportional gain and amplitude setpoint were optimized for each experiment. Images
were evaluated by Gwyddion 2.30 software. Data were flattened using the functions level
data by mean plane and line correction by comparing the height median.
3.6.2 Scanning electron microsopy
Scanning electron microscopy was performed by the electron microscopy lab of the
Institute of Materials Science, TU Dresden, using a DSM 982 Gemini (Zeiss, Germany)
SEM. Voltage was set to 1 kV. Image contrast was adjusted by ImageJ.
4 Biopanning Selections to Identify
NoVLP Recognition Elements
Specific and high affine recognition elements against noroviruses would be highly desirable
for rapid pathogen identification at acute gastroenteritis outbreaks, as explained in section
2.2.6. Thus, this thesis studied the applicability of the biopanning technique to select
peptide binders specific against norovirus like particles (NoVLPs). Therefore, several
experiments were performed and will be described and discussed in this chapter. Initially,
NoVLPs were analysed by atomic force microscopy. The next two sections present the
biopanning experiments based on chromatography, as well as the analysis of the selections
by next-generation sequencing. The chapter concludes with a discussion of the results.
4.1 High resolution microscopy of NoVLPs
NoVLPs were obtained from Riboxx GmbH, Germany (see section 3.1.2). To check their
integrity, NoVLPs were analysed by atomic force microscopy (AFM) as described in
section 3.6.1. NoVLPs of genotype II.4 cluster Grimsby (NV II.4 Grimsby) could be
immobilised on 3-aminopropyldiethoxymethylsilane (APDMES) functionalised silicon
dioxide surface, since the negatively charged NoVLPs can bound to the positively charged
amino terminated silane. Fig. 4.1 A shows the NoVLP sample with numerous round par-
ticles. Their typical diameter was determined to be 20 to 30 nm, but some particles show
values of up to 40 nm. Besides this variability in size, they appear to have got flattened
due to the immobilisation on the surface, since the maximal height was determined to be
16 nm. By contrast, no objects higher than 2 nm could be found for PBS on an APDMES
surface as a negative control (Fig. 4.1 B). Most literature indicate a size of about 38 nm
for intact noroviruses [25] and NoVLPs [23, 34]. However, De Rougemont et al. measured
varying diameters for different NoVLP strains by AFM. Besides an average size of 36 to
38 nm for NV II.4 Den Haag and other strains, NV II.4 Hunter and Bristol particles were
analysed to have a diameter of 29.6 ± 3.3 nm, and 21.3 ± 4.7 nm, respectively. Notably,
they also checked Hunter VLPs by electron microscopy and determined a diameter of
35 nm [46]. Since the size of the objects measured here was in the range described in
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Figure 4.1: AFM image of A) NoVLPs (NV II.4 Grimsby) diluted in PBS, and immobilized on
APDMES, inset B) PBS as negative control. Height and length scale applies to both images.
literature, it could be concluded that the VP1 capsid proteins were able to self assemble
to virus like particles. Nevertheless, they might have formed smaller aggregates than
expected.
Although stable at acidic and neutral pH, NoVLPs have been found to reversibly dis-
assemble under alkaline conditions [35, 139]. Ausar et al. monitored the VLP size over
a pH range of 3 to 8 using dynamic light scattering (DLS) and transmission electron
microscopy (TEM), and observed a strong decrease in particle size from 45 nm (DLS) or
37 nm (TEM) at pH 7 to 25 nm at pH 8. Very few intact particles could be observed by
TEM at pH 8, but by changing the pH back to 7, fully assembled capsids could be found
again [35].
In nature, 180 VP1 molecules are organized in 90 dimers to form one particle (VP1180) [25],
but under alkaline conditions, Shoemaker et al. observed the formation of smaller inter-
mediate structures. They monitored the norovirus disassembly and assembly by mass
spectrometry. At pH 8, they found intact particles as well as VP1 dimers and larger
oligomers, predominantly consisting of 60 VP1 copies (VP160). At pH 9, no VP1180 could
be observed, but additionally to the intermediate structures described for pH 8, particles
consisting of 80 VP1 copies (VP180) had formed. By AFM imaging, they found particles
with varying diameters at pH 9, predominantly between 22 and 26 nm. This fits to
VP160 molecules, which are stated to have a size of around 22 to 23 nm, and presumably
also to VP180 particles. They assume that under alkaline conditions the virus capsid
might dissociate to small VP1 oligomers (primarily dimers), which then reform to larger
oligomers [139].
NoVLPs used in this work were delivered in a pH 9 buffer. Sample dilution and immobli-
sation for AFM were performed in PBS pH 7.4. Thus, the smaller particles observed here
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could be intermediate structures, probably VP160 or VP180 molecules. They might have
formed due to the alkaline pH in the storage buffer, and were not able to fully reassemble
to VP1180 capsids with decreasing pH during the experiment, or they predominate in
this specific NoVLPs strain as it was described by De Rougemont et al. (see above) [46].
For precise clarification further AFM or electron microscopy imaging would be necessary.
However, in the context of biopanning the size of the particles in the sample of interest
corresponds well to the expected presence of NoVLPs.
4.2 Chromatographic biopanning
As a standard technology for separating biomolecules in numerous applications, chroma-
tography may also be attractive for biopanning purposes. This section presents and
discusses the results of the chromatographic biopanning against NoVLPs, reaching from
the actual biopanning process up to next-generation sequencing data analysis and the
performed binding tests.
4.2.1 NoVLP characteristics in chromatography
To conduct biopanning selections against NoVLPs in combination with column chroma-
tography, it was essential to firstly study the behaviour of the particles during the
chromatographic process. Chromatographic conditions had to be found at which NoVLPs
can bind to the column matrix, but phages pass through. In preliminary experiments
column types, dilution buffer, and pH were varied (data not shown). The aim was
to employ two different chromatographic columns to vary the background during the
biopanning selection. The HiTrap IMAC column charged with Nickel ions was chosen
for immobilized metal ion affinity chromatography (IMAC), as well as the CIM R© SO3
disk monolithic column for ion exchange chromatography (IEX). More information about
the chromatographic technique can be found in Materials and Methods 3.2.2. Strongest
binding to the columns was observed when NoVLPs were suspended in bidistilled water,
and when chromatography was run with phosphate buffer at pH 6.5 to 6.8. An exemplary
chromatogram for NoVLP binding to the CIM R© SO3 column can be seen in Fig. 4.2.
It shows the absorbance at different wavelengths during the chromatgraphic process
(expressed in flow volume). Additionally, the chromatogram indicates the relative NaCl
concentration and, based on this, the conductance (secondary axis). A flow volume of
0 ml in the chromatogram corresponds to the time of sample application to the column.
NoVLPs could be tracked at a wavelength of 220 nm (see section 3.2.2).
Although a considerable amount of the NoVLP sample passed through the column (narrow
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Figure 4.2: Chromatogram for NVII.4 Grimsby VP1. 19µg of NoVLPs were suspended in 1 ml
bidistilled water, and injected (section I). Chromatography was run at pH 6.8, and absolute
absorbance was monitored (blue: 220 nm, red: 270 nm) over flow volume. Elution of NoVLPs
(section II: peak 1 and 2) was initiated by increasing NaCl concentration (relative NaCl
concentration: green, absolute conductance: brown).
peak up to 40 mAU in section I of the chromatogram), a sufficient large proportion of
the sample was able to bind to the column matrix, and could be eluted by increasing
NaCl concentration (section II), as explained in section 2.4.2. In most cases, NoVLP
elution resulted in two merging peaks (indicated as 1 and 2), often with a strong tailing
as in the presented chromatogram. Here, tailing could imply at least a third peak.
Nevertheless, tailing was not always present in contrast to the first two peaks, suggesting
that they include the particles. Since it was not possible to state with certainty if
NoVLPs correspond to both or only a single peak, or if the different peaks represent the
intermediate structures discussed in section 4.1, and VP1180 capsids, respectively, both
relevant fractions were processed during biopanning.
NoVLP II.4 Grimsby with histidin-tag have a theoretical pI of 6.3 (calculated by Protein
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Calculator version 3.4). Although the pI does not give a certain prediction about the
surface charge, it can serve as an indicator for its behaviour in IEX. Since negative charges
dominate at a pH higher than the pI, noroviruses can be purified by anion exchange
chromatography [140, 141]. However, phages M13 have a pI of 4.3, and will bind even
better to an anion exchange column. Although the chromatographic behaviour of the
NoVLPs was not optimal in cation exchange chromatography, conditions were found in
which a sufficient portion of NoVLPs bound to the column matrix. The same conditions
were tested in affinity chromatography. Here, monitoring is more difficult, since imidazole
as part of the binding and elution buffer also absorb UV radiation at 280 nm [142].
NoVLP elution by high imidazole concentration resulted in an extra peak, integrated in
the imidazole peak (data not shown).
When applying the same conditions to phages running in IEX or affinity chromatography
(1010 M13K07), a big peak was visible directly after sample application to the column,
but no peak was observed during elution (data not shown). Thus, phages were not able
to interact with the columns and the determined parameters could be transferred to the
biopanning selection.
4.2.2 Biopanning process
To identify NoVLP-binding peptide motifs, a complex biopanning experiment was per-
formed. Briefly, it consisted of three rounds of panning with an inserted cosmix-plexing R©
(Fig. 4.3). Initially, two selection rounds on different columns were performed. The
chromatographic procedure is described in detail in section 3.2.2. Round 1 was carried
out on a HiTrap IMAC column, using affinity chromatography. 1×1012 phages of the
original ENTE1 phage display library were mixed with 120µg II.4 Grimsby NoVLPs in
1 ml bidistilled water, and applied to the equilibrated column. During elution, the fraction
of the NoVLP extra peak and the one directly afterwards were collected and further
processed. At first, the titer of collected phages was determined, and both fractions
were used to infect bacteria. Next day, the produced phagemid DNA was packed into
phage particles. These phages were amplified overnight, and subsequently purified and
quantified. All applied methods can be found in section 3.2. Phage numbers of all rounds
prior to and after amplification are collected in Table 4.1.
All further biopanning rounds were based on ion exchange chromatography, using a
CIM R© SO3 column. 5×109 phages of the amplified panning output of round 1 and 40µg
II.4 Grimsby NoVLPs were added to 1 ml bidistilled water. Elution resulted in a double
peak with tailing. The two peaks corresponded to fraction A6 and A7, respectively,
which were further processed as A6_R2 and A7_R2 for cosmix-plexing R© in parallel
and independently of each other. Cosmix-plexing R© results are described and discussed
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Figure 4.3: Schematic presentation of the chromatopanning process, showing for each round
the chromatographic column used (HiTrap or CIM R© SO3, as well as the fractions prepared
for NGS, and the corresponding NGS sample name. For round 2, fractions also correlate
with the ones used for the next biopanning round.
Table 4.1: Absolute input and output phage number during biopanning selections and after
amplification. Wash fractions of the negative selection were used as panning input for
PA6_R3+NP.
R1 HiTrap A6_R2 A7_R2 PA6_R3 PA7_R3
panning input 1.0×1012 5.0×109 5.0×109 2.0×1012 1.0×1012
panning output
(10 ml)
1.0×107 4.2×106 3.3×106 6.4×107 3.0×107
amplified panning
output (200 µl)
5.0×1010 1.0×1011 9.0×1010 - -
NP PA6_R3+NP
panning input 2.5×1012 NP
panning output
(10 ml)
3.3×106 1.5×106
amplified panning
output (200 µl)
- -
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in the next section. Following cosmix-plexing R©, one more round of biopanning was
performed using two different strategies. In chronological order, round 3 was initiated by
two biopanning selections based on the two fractions of round 2, resulting in two phage
pools PA6_R3 and PA7_R3. In these experiments, 2×1012 and 1×1012 were mixed with
40µg II.4 Grimsby NoVLPs, respectively. Eluted fractions A6 and A7 were combined
each time and further processed for next-generation sequencing.
Due to the obtained results (see sections 4.3.2 and 4.3.3), a further biopanning based
on the A6_R2 phage pool was conducted. It included a negative selection (NP) prior
to the actual selection (PA6_R3+NP). For negative selection, 2.5×1012 A6_R2 phages
underwent the same chromatographic procedure as during biopanning, but without
NoVLPs. Phages not able to bind to the column matrix were eluted during washing and
these wash fractions were used in the subsequent selection round. By contrast, phages
collected during elution were prepared for NGS to analyse these background binders.
In the actual selection round, wash fractions of the negative selection and 40µg II.4
Grimsby NoVLPs were mixed again for chromatography. Elution of the NoVLPs with
bound phages resulted in only one peak this time. As for the other experiments, relevant
fractions were processed for NGS.
4.2.3 Cosmix plexing R©
After the second round of biopanning, cosmix-plexing R© was performed as described in
section 3.2.7. A summary of the results is presented as one gel electrophoresis image in
Fig. 4.4.
Prior to the series of enzymatic restriction digest and ligation, phagemid DNA was
isolated and checked by agarose gel electrophoresis, showing three distinct bands (lane 1),
as expected for prepared phagemid DNA. The one which passed through the gel with
the highest mobility (furthest distance) is the covalently closed circular (ccc, also called
supercoiled) form, the most common conformation. A small amount of prepared plasmid
DNA commonly is linear (lin) due to a nick (dna strand break) in both strands, or open
circular (oc, lowest speed) due to a nick in one strand. DNA was then cleaved by BpmI at
the recombination side in the hypervariable region, resulting in linear fragments (lane 2).
Ligation at high DNA concentration led to concatamers (lane 3) with newly recombined
phagemid sequences. Concatamers were cleaved by BglI at the resolution site (lane 4).
Recombined phagemid fragments were re-circularised by ligation at low concentration
(lane 5), and purified (lane 6). Finally, DNA was successfully transformed, resulting in
5.5×108 and 6×108 cfu/50 ml for A6_R2 and A7_R2, respectively. The recombined
phage library was then prepared as described in section 3.2.7.
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Figure 4.4: Cosmix plexing R© process shown by gel electrophoresis. 1 µl of phagemid DNA
after each step was applied to the gel (left: results for fraction A6_R2, right: results for
fraction A7_R2). Lane M: marker for dsDNA (size is indicated in bp only for the bright
bands), lane 1: undigested phagemid DNA (ccc - covalently closed circular form, lin - linear
form, oc - open circular form), lane 2: after BpmI restriction, lane 3: concatamer formation,
lane 4: after BglI restriction, lane 5/6: circularised phagemid DNA (5: low concentration, 6:
purified).
4.3 Next-generation sequencing analysis
Due to the physical linkage between phenotype and genotype of the phages - the infor-
mation for the presented peptide is located in the phage genome - selected peptides do
not have to be isolated and analysed labour-intensively, but can be studied at DNA level.
Next-generation sequencing, as explained in section 2.4.3, allows the investigation of all
sequences of a particular phage pool.
4.3.1 Preliminary considerations
To analyse the chromatopanning experiments conducted within this thesis, six phage
pools were processed for next-generation sequencing analysis. They are depicted in blue
in Fig. 4.3. Two interesting fractions emerged from the second round of biopanning,
namely A6 (A6_R2) and A7 (A7_R2). After cosmix plexing R© (round 3), three different
pannings were analysed: the selection based on A6_R2 (PA6_R3), the one based on
A7_R2 (PA7_R3), and the additional biopanning experiment with a negative selection,
also originating from A6_R2 (negative panning: NP, selection: PA6_R3+NP). From a
chronological point of view, A6_R2, A7_R2, PA6_R3, and PA7_R3 belong to the first
chromatopanning project (Chromatopanning I). After NGS analysis and binding tests, a
second experiment was performed including NP and PA6_R3+NP (Chromatopanning
II).
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Table 4.2: NGS data overview, showing the number of total and valid sequences, as well as the
number of distinct 3-mer and 4-mer motifs, and the titer of the panning output. The library
pattern applied in LibDB was ENTE1 as the original library.
A6_R2 A7_R2 PA6_R3 PA7_R3 NP PA6_R3+NP
Total
sequences
447,611 386,187 660,989 246,350 777,736 1,104,676
Valid
sequences
263,512 220,410 307,914 82,025 360,790 497,816
3-mer
motifs
7,253 7,253 7,252 7,250 7,252 7,254
4-mer
motifs
132,071 131,986 132,071 128,143 132,093 132,164
Panning
output
4.2×106 3.3×106 6.4×107 3.0×107 3.3×106 1.5×106
As described in section 3.4.4, for each phage pool the plasmid region of interest was
amplified by PCR. PCR products were purified and sent for NGS. Finally, sequence data
were evaluated using the software LibDB. Here, it has to be considered that initially, for
the evaluation of the first chromatographic project, the software was not yet developed.
Nevertheless, preliminary considerations based on LibDB will be retrospectively treated
in this section for all runs.
Table 4.2 shows the summery of the obtained number of sequences. 1×105 to 1×106
sequences could be analysed for all phage pools. Sequences not matching the intended
pattern of the ENTE1 library were not further processed. The resulting sub-quantities
of valid sequences represent about half of the total number of sequences. A number of
150,000 valid sequences is mentioned as critical minimal threshold for a primary motif
search [143]. Only PA7_R3 did not meet this condition with 82,025 valid sequences, so
all results referring to this data set have to be treated with caution.
In addition, the number of valid sequences should ideally not differ by more than factor
10 from the phagemid titer of the panning output, to ensure sufficient coverage of at
least enriched motifs [143]. Here, all phage numbers were higher than the number of valid
sequences, in the range of factor 10 for A6_R2, A7_R2, PA6_R3+NP and NP, but of
factor 200 for PA6_R3 and even of factor 375 for PA7_R3. Again, this has to be kept
in mind during analysis. 7,255 3-mer motifs and 132,217 4-mer motifs are noted for the
native ENTE1 library. Hence, variability of sequence pools is still extremely high, as
almost all possible motifs can be found in all six samples. With regard to full sequences,
Fig. 4.5 shows the frequency of sequences with a particular number of occurences (counts)
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Figure 4.5: Frequency of sequence counts. For each biopanning run, percentage of sequences
occurring a certain number of times (1 - 2 x, 3 - 9 x, 10 - 99 x, 100 x and more) is indicated.
Round 2 runs are displayed with stripes, round 3 experiments without. Mind the interrupted
vertical axis.
for each selection experiment. The great majority of sequences was counted only once or
twice. This category covers more than 90 % of sequences for A6_R2 and A7_R2, as well
as PA7_R3. Except the latter, in all runs of round 3, sequences occurred less frequently
only once or twice, but more often with an increased number of counts. In round 3, the
frequency of sequences with 3 to 9 counts is two to five times higher relative to round
2, and counts higher than 9 occur for the first time with a frequency of more than 1 %.
Counts higher than 99 can also be detected to a small extent. It may thus be concluded
that an enrichment of sequences has taken place. This is more pronounced in round 3
than in round 2, with the exception of PA7_R3, in which a depletion has to be noticed
compared to round 2. Hence, this sample was excluded from further analysis.
4.3.2 TopN sequences and motifs of Chromatopanning I
Based on this first overview, the topN sequences and motifs (sequences and motifs in
decreasing order of frequency or enrichment, respectively) were closer examined. The
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top30 sequences of all six phage pools are exemplarily listed in Table 4.3. Initially, only
the biopanning experiment including A6_R2, A7_R2, and PA6_R3 had been performed,
but anticipating, also PA6_R3+NP and NP can be found in this list.
As the first impression, it is obvious that in most sequences, independent of sample type,
histidine is the most frequent amino acid. In most cases, H occurs more than one time
per sequence. Multiple H’s in a row, or in a H*H format (* represents any single amino
acid) can be found. The abundance of H was supported by checking the top400 4-mer
motifs. Here, the motifs with the highest enrichment contain at least one H, and in most
cases, even combinations of 2 to 4 H’s.
The first panning round was conducted using immobilized metal ion affinity chromato-
graphy, favouring a binding of the histidin-tagged NoVLPs to the Ni2+ charged chelating
groups of the column matrix. Phages displaying peptides which are able to interact with
NoVLPs were retained during chromatography, but since NoVLPs will not occupy all
binding sites on the column matrix, phages displaying peptides with binding activities
similar to histidin tags might have also been enriched. Further biopanning rounds were
based on cation exchange chromatography. Since H is an amino acid with a positively
charged side chain at the given pH of 6.5 to 6.8, phages presenting these peptides most
likely were able to bind to the negatively charged column matrix.
After H, the following amino acids had an apparent high frequency in the top400 motifs
of all runs: Q (polar), V (hydrophobic) and W (hydrophobic and aromatic), as well as E
(negatively charged) in round 2, and P (small) and R (positively charged) in round 3.
Since LibDB was not yet developed after performing the first project part, a listing of all
motifs ordered by their enrichment relative to their theoretically expected frequency was
not yet possible. Nevertheless, motifs could be listed due to frequency, or due to their en-
richment during biopanning (run after cosmix-plexing R© vs. run before cosmix-plexing R©).
Here, motifs of PA6_R3, ordered by their enrichment relative to A6_R2, were analysed.
Based on this motif analysis, two sequences were selected to be tested in NoVLP ELISA
binding tests. Peptides to be synthesized are listed in Table 4.4. They were chosen due
to the sequences’ likelihood to be an appropriate NoVLP binder.
Peptide 1 was the most promising one, not only because it was the second most frequent
sequence of PA6_R3, and the one with the highest enrichment relative to A6_R2.
Moreover, the part IWHSKQHPRPGR could be found in combination with different
sequence endings, being clearly a result of the cosmix-plexing R© strategy. It includes the
interesting motif PRP(GR), meeting expectations on a binding motif. The P’s enforce
a turn in the structure, so the motif does not have to be N-terminal to be exposed. A
short form of this sequence was defined as an extra peptide to be tested, indicated as
peptide 3. The VKH motif contained in peptide 2 was also a very frequent one, and since
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Table 4.3: Top30 sequence list for all runs as a representation of the topN sequences.
A6_R2 A7_R2 PA6_R3 PA6_R3+NP NP
1 TRHCNGVSHHRPHSHA TRHCNGVSHHRPHSHA KFHSHKPHLHQGHHVF KFHSHKPHLHQGHHVF KFHSHKPHLHQGHHVF
2 HHMSIPRHCHWLHKGC SHACAWRVHRRSDAPI IWHSKQHPRPGRAQQY IWHSKQHPRPGRAQQY IWHSKQHPRPGRAQQY
3 HSHSRWSNFQRFPHLA YKHSGNWRSNKHQVNN KISSYAHHHKCRHQFC KISSYAHHHKCRHQFC KISSYAHHHKCRHQFC
4 IWHSKQHPRPGRAQQY IWHSKQHPRPGRAQQY TIHSRWRHPLWSHGHF HKSCVDVVCFRETHPA TIHSRWRHPLWSHGHF
5 YKHSGNWRSNKHQVNN WHWCRKWWRACGHTSC HHMSIPRHCHWLHKGC TIHSRWRHPLWSHGHF HHMSIPRHCHWLHKGC
6 SKGCYWKHCKKDAANI VFHSITNRCPEQYQVY WNQSHHAHVHRHRIHF HHMSIPRHCHWLHKGC HKSCVDVVCFRETHPA
7 VHHCHLHWRHCLDPFI IHNCDTVKKHEYLGLI HKSCVDVVCFRETHPA AHRSPTKEQLRIRHTA IRHSHPIKKPRIEYLN
8 IRLCPNLYEVGTSPHI YENCLSYVHQPFVCQD YKLSFHHHHHRPTQHI NTQCYTEAHFQKGFSD SKGCYWKHCKKDAANI
9 KISSYAHHHKCRHQFC YLGSVVHSLHGHTAQA HSHSRWSNFQRFPHLA YKLSFHHHHHRPTQHI YKLSFHHHHHRPTQHI
10 AHRSPTKEQLRIRHTA LVHCFKVSRKKLAIGC KRHSFPGWHPWHPQHF VVTSRWKHHHQYHPAN SKRCHKWNCHQHKPYF
11 EDPSDDAWIVESALSY NSMSDVPARVGFIYKD VRHCPRFLHHKIPCQI IRHSHPIKKPRIEYLN HSHSRWSNFQRFPHLA
12 KFHSHKPHLHQGHHVF SNHCLNSGHPWVVQIC TRHCNGVSHHRPHSHA KIQSHARPSTWKKPHF KRHSFPGWHPWHPQHF
13 VVSSLSWKPGQHKHHC VVSSLSWKPGQHKHHC SKGCYWKHCKKDAANI SKGCYWKHCKKDAANI IIHSLHHGHPRRPGIA
14 TKTCINFATFIYIAYF VTRCFGRHGFQKPAFD SKRCHKWNCHQHKPYF EDPSDDAWIVESALSY VVTSRWKHHHQYHPAN
15 VYSSHTTHPHKPRHPN AHRSPTKEQLRIRHTA IRHSHPIKKPRIEYLN SKRCHKWNCHQHKPYF TRGCKFWIHYKHPHVC
16 LVHCFKVSRKKLAIGC EEWSSYGKDPWQGELF NKPSARHHHHPFHGRI IKGCHRHPCIWNHPHY PRWSVQHHHFYNHFHA
17 IRPCWFHKGVKHQRQC ETFCSRHLENQERTYC VRHSHNPHRYWFVHPY HSHSRWSNFQRFPHLA IKGCHRHPCIWNHPHY
18 IIQCVQLFEFCAFNPY HHMSIPRHCHWLHKGC VVTSRWKHHHQYHPAN VYSSHTTHPHKPRHPN KFQSKWAPLHWQHHTA
19 KIGSIKVNFVPCSKSD QLRCHPWWHSWSLKNA TRGCKFWIHYKHPHVC VRHCKKWHVVPLQGRC VKHSWWAQHKPGRPAA
20 SNHCLNSGHPWVVQIC KISSYAHHHKCRHQFC KRPSRWWFHTQDHHNY IIHSLHHGHPRRPGIA IHHSQHQHKPRQRPFA
21 YENCLSYVHQPFVCQD SKQCQGLQTSRIYIVF HRHSWNAQHHKQQQSY SHQCHHHHHPIRQRHC KLNSKPVHHPKHQYLI
22 YLGSVVHSLHGHTAQA VRHSKWHALHKCSAQD HHQCWPFHSCKFRHHD VRHCPRFLHHKIPCQI TRHCNHWKRNCTNPLF
23 FHFSHEKVHTCKRAHI VRNCGTRPVEKYTSPI VQRCKAHWCHRHHTFN HRHSWNAQHHKQQQSY PRPCHRWHFGQQQKHC
24 YFSCSDTNGFWHIQDI VTNCFVFFQSCLQFYI VHHSRYPWHVWKRPQD LIVSIYVKEGWQQLVA NTQCYTEAHFQKGFSD
25 DFFSVGYESPQTHYQN GELCWHQRRIEFVIQC PRACKVAHHFWCIKQA TRGCKFWIHYKHPHVC HHQCWPFHSCKFRHHD
26 EWLSVNENVAPIPHPF EDPSDDAWIVESALSY LVHSPPKHHRWRGHYF PRPCHRWHFGQQQKHC NWHSHHPPHQKHPRKD
27 HQWSFHDKCHRFIQTY RQNCYVAIADPVNEVA TRHCPNWHCFKHHGPI KRHSFPGWHPWHPQHF VHHSRYPWHVWKRPQD
28 HKSCVDVVCFRETHPA HKHCSQAQVKIGPFLI PRHCGHWFRPQRFYCN DIVCYTRPERESASCY VRHCPRFLHHKIPCQI
29 QVHSHRNHAHGPIACI ILACRIKTKSGKHDHD VRHSKWHALHKCSAQD VGHCVRRWHFPCKYQI QKHSHKNWPHPLRTRF
30 KRHSPHAHNCWLHNCF TKTCINFATFIYIAYF PRHSTRFHHHKGYFTF AIQSDWSFFFWTTREF IPPCGWFKHCRHPFHF
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Table 4.4: Sequences selected for peptide synthesis.
Peptide sequence Full sequence in biopanning
1 IWHSKQHPRPGR IWHSKQHPRPGRAQQY
2 VKHCIWRKCRP VKHCIWRKCRPAAVPY
3 HPRPGR IWHSKQHPRPGRAQQY
4 SIHQKHPGPWRR randomized sequence of peptide 1 as negative control
the sequence included the interesting CRP motif, it was chosen as an alternative for the
binding assays. Peptide 4 represented a randomized sequence of peptide 1 as negative
control.
4.3.3 ELISA binding tests
The four synthesized peptides (Table 4.4) were tested in enzyme linked immunosorbent
assays (ELISAs). Initially, the ELISA plate was coated with 20µg/ml of II.4 Grimsby
NoVLPs, and 10µM of peptides were added after blocking as described in Materials and
Methods 3.3. A binding should be detected by the subsequent addition of horseradish
peroxidase (HRP)-conjugated streptavidin. As positive controls, wells were directly
coated with peptide, and coating with blocking buffer was used as negative control. As
second negative control, peptides were replaced by blocking buffer. Multiple ELISAs
were performed to successively optimize the parameters listed in Table 4.5, but a specific
binding of peptide 1, 2 or 3 to NoVLPs relative to the blocking buffer could not be
verified. Nevertheless, the following preliminary statements could be made: peptide 1
bound to the blocking negative control as well as to NoVLPs with high affinity, and was
even overtopped by peptide 2. By contrast, no or only a very low signal could be detected
for the binding of peptide 3 and 4 to the blocking agent and NoVLPs.
Since background binding was so high, blocking and washing steps were modified. Non-
fat dry milk (NFDM) for blocking, and a more stringent washing could reduce the
unspecific signal, but binding to NoVLPs was decreased accordingly. Eventually, instead
of immobilising NoVLPs and adding the peptides, the assay was conducted reversely.
Peptides were immobilised, and after blocking, 10µg/ml of NoVLPs were added. Binding
of 1µg/ml NoVLPs to peptides should be detected by an antibody directed against the
histidin tag of the particles (mouse anti-6x his epitope tag antibody), which again was
bound by a HRP-conjugated secondary anti-mouse antibody. Here, no signals could be
detected except for the positive control (directly coated NoVLPs). Since the blocking
agents could hinder the interaction between peptides and particles, next time peptides
were immobilised in a high concentration (10µM) to occupy the whole well surface, and
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Table 4.5: Parameters modified for peptide ELISA
Parameter Options Result
Streptavidin-HRP 1:4,000 only slight signal decrease with
dilution 1:10,000 1:10,000 relative to 1:4,000;
further experiments with
1:10000
Blocking buffer BSA 1 mg/ml lowest background signal for
BSA 1 mg/ml+NFDM 0.5 % all NFDM combinations,
NFDM 0.5 % followed by BSA;
NFDM 0.5 % sterile filtered high background signal for
NFDM 5 % PEG and Tween-20;
PEG 200 nM further experiments with
PEG 20 nM NFDM 0.5 % sterile filtered
Tween-20 0.05 %
pH (coating, pH 7.4 or 6.8 without influence
blocking, washing)
Peptide
concentration
10µM, 1µM, or 100 nM concentration dependent signal,
but no influence on specificity of
binding
Wash stringency 5 min incubation in each 3rd
wash step
reduction of unspecific and
specific signal
only Tween-20 was used for blocking. A murine norovirus polymerase with histidin tag
(MNV-N57) was applied as negative control. A low, but slightly increased signal could be
observed for the binding to NoVLPs relative to the negative control in this assay for all
four peptides, suggesting that the anti-histidin tag antibody might only detect deviations
in histidin-tagged protein concentration. The positive control gave a much more higher
signal.
In summary, the first ELISA layout strategy (immobilisation of target and addition of
peptides) seem to be more suitable to check the affinity and specificity of selected peptide
candidates than the second strategy (immobilisation of peptides and addition of target).
Based on the performed ELISAs, peptide 1 and 2 very likely represent unspecific binders
with a high affinity to both NoVLPs and background. The short form of peptide 1,
peptide 3, did not bind at all. Peptide 4, consisting of the same amino acids as peptide
1, but in a randomized order, bound with a much lower affinity than peptide 1 to both
particles and background.
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4.3.4 TopN sequences and motifs of Chromatopanning II with
negative selection
With regard to the ELISA results, a further biopanning experiment with included negative
selection was performed based on the existing phage pool after cosmix-plexing R©. On the
one hand, a negative selection prior to the actual selection round was expected to reduce
the number of phages binding unspecifically to the chromatographic background, since
only phages passing through the column were processed for the selection experiment. On
the other hand, due to the possibility of high throughput analysis, phages retained in the
column during negative selection could be evaluated by NGS.
Regarding the top30 sequences and top400 motifs, the high abundance of H also applied to
the new run PA6_R3+NP. Again, Q, W, and V dominated the top400 motifs, but clearly
less pronounced than H, followed by R and P. Most important, the negative panning
NP could not be distinguished from the biopanning runs, neither by topN sequences
nor motifs. Thus, topN sequences and motifs did not give any support in differentiating
positive from negative selection.
At that time, the development of LibDB had proceeded, and the software now enabled a
listing of all potential motifs with regard to their actual relative frequency of occurrence
(calculation see section 3.4.4). Additionally, LibDB determines the theoretically expected
frequency. The difference between occurred and expected frequency defines the enrichment
of a motif. Hence, LibDB now allowed a sorting of all motifs by their occurred frequency,
or their enrichment. Therewith, a screening for motifs enriched during biopanning, but
not during negative selection, was possible for the first time and will be explained in
more detail below.
Initially, the occurred frequencies of the original ENTE1 library were compared to the
theoretically expected frequencies of motifs. Based on that, motifs were sorted by their
enrichment in ENTE1. It was found that frequencies of motifs were not equal to the
expected frequencies. Therefore, the enrichment was not 0, but ranged from -2.1 to 0.7.
This might be a consequence of minor frequency variations for each single amino acid,
compared to the expected frequency, and was taken into account in the further analysis.
Most surprisingly, in the most enriched motifs (top400) of the ENTE1 library the amino
acids H, Q, V, and E, strongly dominated, followed by C and W. Top100 motifs almost
exclusively consisted of combinations of H, Q, V, and E, with enrichments between 0.6
and 0.7.
Comparing the top400 motifs of the orginal ENTE1 library and of the biopanning selection
runs added another perspective to the amino acid distribution of the latter. With regard
to H, the enrichment seemed to be not only a result of the use of the HiTrap IMAC
column, but also of the pre-existing H dominance. Nevertheless, the abundant series of
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H found in the biopanning top400 motifs were clearly caused by the chromatographic
strategy, and in most samples the percentage of motifs containing H was anyway higher
than in the ENTE library. By contrast, the apparently enriched amino acids Q, V, and E
have actually been reduced from round to round, relative to the original library. A slight
enrichment relative to the original library, and from round to round, could be found for
A, F, G, K, L, N, S, and T, but especially P, R, and W are remarkably enriched. As
previously described, the negative selection showed an amino acid distribution pattern
similar to the ones of round 3.
As a conclusion from the top400 motif analysis of the original library, runs must not be
compared to the expected values, but to the original library. Based on these preliminary
studies, differences between negative selection and biopanning runs were identified and
closer examined. Therefore, full motif compilations (160,000 different 4-mer motifs) of all
runs were jointly listed. Enrichment relative to the expected frequency was replaced by
enrichment relative to the frequency of the original library. After careful consideration,
certain thresholds were set to compare negative selection and round 3. Initially, motifs
with less than 10 counts in round 3 (PA6_R3 and PA6_R3+NP) were excluded from
further analysis. To screen for motifs enriched in both round 3 experiments, the enrichment
of PA6_R3 and PA6_R3+NP was averaged, and only enrichments greater or equal to 0.3
were considered further. Then the difference of the enrichment of round 3 and negative
selection was calculated for each motif, and differences lower than 0.3 were also excluded.
Applying these rules, number of motifs was reduced from 160,000 to 185. These motifs
are exemplarily listed in Table 4.6 for differences ≥ 0.4. In this sorting, combinations of
W and K with R, N, and F are especially prominent. Interesting motif candidates were
now further processed for the motif neighbourhood analysis.
Table 4.6: Motif selection based on the average enrichment in round 3 relative to ENTE1
(enrichment ≥ 0.3, counts for PA6_R3 and PA6_R3+NP ≥ 10), sorted by the difference in
enrichment relative to NP (≥ 0.4).
Motif A6_R2 A7_R2 PA6_R3 PA6_R3+NP NP Avg R3 Avg R3 - NP
KKNL -0.25 -0.35 0.49 0.18 -0.86 0.33 1.19
DGGA 0.24 0.10 0.32 0.52 -0.59 0.42 1.01
LPNW 0.07 -0.55 0.48 0.30 -0.46 0.39 0.85
KRWW 0.04 0.11 0.72 0.43 -0.28 0.58 0.85
KLKT 0.09 0.09 0.39 0.27 -0.52 0.33 0.85
WRTK 0.11 0.23 0.40 0.35 -0.46 0.38 0.84
KKKW -0.28 -0.20 0.80 0.56 -0.12 0.68 0.79
DRWR 0.13 -0.40 0.41 0.29 -0.43 0.35 0.79
LKKK 0.59 0.61 0.82 0.53 -0.03 0.68 0.70
WKNW 0.16 0.54 0.49 0.36 -0.28 0.43 0.70
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Table 4.6: Motif selection based on the average enrichment of round 3 (continued).
Motif A6_R2 A7_R2 PA6_R3 PA6_R3+NP NP Avg R3 Avg R3 - NP
DSKK -0.44 0.24 0.49 0.28 -0.28 0.39 0.66
DLDA 0.47 0.50 0.68 0.68 0.03 0.68 0.65
AAGD 0.48 0.38 0.54 0.46 -0.13 0.50 0.63
TPKK 0.31 -0.27 0.36 0.25 -0.31 0.31 0.62
NFAL 0.04 0.26 0.38 0.27 -0.29 0.32 0.61
DWLK 0.07 0.20 0.38 0.31 -0.27 0.34 0.61
PKKR 0.49 0.54 0.50 0.56 -0.08 0.53 0.61
NLWN 0.19 -0.20 0.29 0.35 -0.29 0.32 0.61
YCWR 0.33 0.23 0.38 0.49 -0.16 0.44 0.60
RNKS -0.04 -0.74 0.44 0.23 -0.26 0.33 0.59
LRTK -0.04 0.11 0.40 0.41 -0.18 0.40 0.58
KKGF 0.16 0.34 0.27 0.34 -0.28 0.31 0.58
ANKW 0.28 -0.12 0.47 0.34 -0.16 0.40 0.57
KRAD 0.06 0.17 0.40 0.26 -0.23 0.33 0.57
RWWK 0.54 0.35 0.47 0.58 -0.04 0.53 0.56
RKEK 0.36 0.16 0.43 0.31 -0.20 0.37 0.56
LIGW 0.46 0.11 0.49 0.43 -0.10 0.46 0.56
LKWF 0.13 0.21 0.40 0.35 -0.18 0.38 0.56
WKKA 0.45 0.05 0.31 0.48 -0.16 0.39 0.55
LKIS 0.10 0.12 0.33 0.43 -0.16 0.38 0.54
TWKD 0.00 0.27 0.29 0.37 -0.20 0.33 0.53
KKKK 0.75 0.35 0.99 0.70 0.32 0.84 0.53
PTGD 0.31 0.23 0.36 0.43 -0.13 0.40 0.52
FFIW 0.44 0.52 0.58 0.42 0.00 0.50 0.50
ALRW -0.47 0.08 0.61 0.37 -0.01 0.49 0.49
RWNW 0.33 0.49 0.89 0.47 0.19 0.68 0.48
ALAT 0.45 0.15 0.51 0.33 -0.07 0.42 0.48
YWVW 0.30 -0.05 0.37 0.29 -0.14 0.33 0.47
LFNK 0.24 0.17 0.37 0.29 -0.14 0.33 0.47
PRWW 0.16 0.11 0.57 0.61 0.12 0.59 0.47
FALT -0.01 0.29 0.42 0.21 -0.15 0.32 0.47
WKKD 0.00 -0.05 0.33 0.32 -0.14 0.32 0.46
RGHW -0.03 0.05 0.31 0.30 -0.16 0.30 0.46
FFFW 0.60 0.78 0.49 0.97 0.27 0.73 0.46
SFRG 0.15 0.23 0.35 0.28 -0.15 0.32 0.46
DAKG -0.33 0.12 0.36 0.49 -0.04 0.42 0.46
TQKK 0.42 0.50 0.70 0.57 0.18 0.64 0.46
FDEA 0.39 0.18 0.25 0.36 -0.14 0.30 0.45
IPTW -0.27 0.32 0.48 0.30 -0.05 0.39 0.44
RNKA 0.44 0.22 0.48 0.27 -0.06 0.38 0.44
NKKK 0.45 0.60 0.88 0.76 0.38 0.82 0.44
LDDS 0.13 0.03 0.36 0.33 -0.09 0.35 0.43
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Table 4.6: Motif selection based on the average enrichment of round 3 (continued).
Motif A6_R2 A7_R2 PA6_R3 PA6_R3+NP NP Avg R3 Avg R3 - NP
HKKN 0.41 0.16 0.49 0.27 -0.05 0.38 0.43
YKRK 0.25 0.33 0.47 0.38 -0.01 0.43 0.43
ARDT 0.40 0.12 0.45 0.33 -0.04 0.39 0.43
YAGP -0.01 0.29 0.29 0.41 -0.08 0.35 0.43
DWLE 0.24 0.19 0.38 0.39 -0.05 0.38 0.43
FFFL 0.46 0.20 0.35 0.46 -0.02 0.41 0.43
AWIY -0.03 0.27 0.37 0.25 -0.12 0.31 0.42
ARFL 0.08 0.06 0.27 0.37 -0.10 0.32 0.42
ICWL 0.11 0.41 0.34 0.28 -0.11 0.31 0.42
FTGA 0.63 0.53 0.61 0.51 0.14 0.56 0.42
KALI 0.20 0.04 0.47 0.49 0.06 0.48 0.42
LFFL 0.30 0.18 0.42 0.34 -0.03 0.38 0.42
KFFW 0.12 0.20 0.63 0.32 0.06 0.47 0.41
GGFF 0.04 0.23 0.27 0.35 -0.10 0.31 0.41
WRWF 0.47 0.51 0.61 0.42 0.10 0.51 0.41
TRRL 0.13 -0.19 0.40 0.30 -0.05 0.35 0.41
KWWL -0.13 0.17 0.56 0.32 0.04 0.44 0.40
RWFH 0.12 0.36 0.38 0.39 -0.02 0.38 0.40
WTFK 0.18 0.22 0.45 0.29 -0.03 0.37 0.40
FFAT 0.10 0.12 0.45 0.38 0.01 0.42 0.40
YEWA 0.21 -0.07 0.27 0.33 -0.10 0.30 0.40
GRRH -0.02 0.16 0.46 0.29 -0.02 0.38 0.40
4.3.5 Motif neighbourhood analysis
Motif neighbourhood analysis is based on the assumption that the specific binding to a
target might not only be mediated by the core motif itself, but that neighbouring amino
acids (adjacent in the sequence, or in a threedimensional sense) might also play a role.
Here, it can be understood as a sort of motif fingerprinting: in the biopanning peptide
pool, the core motif might be embedded in a different amio acid environment than in the
original library.
Motif neighbourhood was exemplarily analysed for selected 3mer motifs out of the 4mer
motif list (Table 4.6). They are collected in Table 4.7. Initially, for a chosen motif, the
motif fingerprint tool of the LibDB software was used to collect the neighbourhood analysis
data for all analysed biopanning runs including the negative selection, as well as for the
ENTE1 library. It shows the amino acid distribution for the five positions before (A5 to
A1) and behind (B1 to B5) the motif. The absolute amino acid numbers for each position
were transformed to relative values to calculate the correlation coefficients r between
biopanning experiments, negative selection, and ENTE1 library. These correlation
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Table 4.7: Motifs selected for fingerprint analysis
Motif group assignment Motifs
FA-containing group FAT NFA
RW-/FW-/WF-containing group KRW RWN RWF GFW KWF RWF
coefficients are a measure of the similarity of two amino acid distributions. An equal
amino acid distribution will lead to r = 1, whereas at r = 0 no correlation is observed.
For each motif, the correlation coefficients were visualised in a matrix, as exemplarily
shown for RWN in Fig. 4.7. Here, the results show that the amino acid distributions of
panning experiments and original library were very similar at the amino acid positions
directly adjacent to the motif (A2, A1, B1 - high correlation coefficients marked in green),
but differed at positions farther away (A5, A4, B2, B3, B4 - medium and low correlation
coefficients marked in yellow and red, respectively).
A2 A1A2A4A5 B4 B5B3B2B1motif
Figure 4.6: Fingerprint analysis encompassing five amino acids before and after the 3mer motif.
All studied motifs except KRW and NFA had correlation coefficients of less than 0.5
between runs and ENTE1 library at at least one position. Three or more positions with
r < 0.5 were found for FAT, RWN, and KWF. Their motif fingerprints were studied in
more detail. Therefore, the difference of each relative amino acid proportion between
biopanning and ENTE1 library was calculated for each run. For RWN, the result is
exemplarily shown in Fig. 4.8 for PA6_R3. This fingerprint analysis shows a diverse
picture of amino acids with increased or reduced frequency of occurrence in the direct
neighbourhood of the motif RWN. The green marked amino acid/position combinations
are the ones with a significant higher percentage of occurrence in the biopanning selection
PA6_R3 than in the original library. Here, especially the enhanced proportion of P at
the position A2 and B3 can be considered to be of interest for the analysis. As already
explained earlier, P is a small amino acid which enforces a turn in the structure, so the
motif does not have to be N-terminal to be exposed, and prolins are likely to be expected
in a binding motif fingerprint matching a small binding pocket (M. Szardenings, personal
communication). P was also enriched at these two positions of the RWN fingerprint in
the other runs of the third round (PA6_R3+NP, and NP), but not that prominent. Since
all runs of the third round were based on the same original phage pool derived from
cosmix plexing, enrichment in the negative panning was likely to be similar to the one
during selection. This fact might be neglected, because motifs studied here were chosen
due to the strong enrichment during selection relative to the negative panning. P was
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             
             
           
         
       
     
   
             
             
           
         
       
     
   
             
             
           
         
       
     
   
             
             
           
         
       
     
   
             
             
           
         
       
     
   
Figure 4.7: Fingerprint correlation analysis exemplarily shown for the motif RWN. Amino acid
positions are A5-A4-A3-A2-A1-RWN-B1-B2-B3-B4-B5. For each position a matrix shows the
correlation coefficients of the amino acid distribution between two experiments. The colour
code indicates the strength of correlation (green/high, yellow/medium, red/low).
also enriched in the FAT fingerprint at position B2, and in the KWF fingerprint together
with H at position B1.
In summary, fingerprint analysis resulted in a differentiated picture. For each motif,
particular amino acids were more or less frequent at certain positions with respect to the
original library. To examine the NoVLP binding affinity of the studied motifs, embedded
in their characteristic fingerprint, additional binding tests would be necessary. The motifs
RWN, KFW, and FAT would be promising candidates for future tests due to their high
enrichment relative to the ENTE1 library and the negative panning, as well as their
fingerprint dissimilarity with respect to the original library, and the upregulation of P
in the motif neighbourhood. Since no additional batches of NoVLPs were available for
testing, further experiments were not part of this work. Thus, this chapter has to be
understood as a demonstration of new analysis possibilities for biopanning data obtained
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
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
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Figure 4.8: Fingerprint analysis exemplarily shown for the motif RWN in the run PA6_R3.
Amino acid positions are A5-A4-A3-A2-A1-RWN-B1-B2-B3-B4-B5. The difference of the
relative amino acid proportion in percent between ENTE1 library and the biopanning run
PA6_R3 is listed for each position and amino acid. The colour code indicates type and level
of the difference (green = enriched, yellow = no difference, red= depleted relative the ENTE1
library).
by next generation sequencing, enabled by LibDB, and realised in cooperation with the
Ligand Development Unit (M. Szardenings) of the Fraunhofer Institute for Cell Therapy
and Immunology, Leipzig.
4.4 Discussion of the chromatopanning results
This thesis resulted in a number of potential norovirus recognition motifs, but their
binding to NoVLPs could either not be confirmed or not yet tested. The reasons for
this outcome might be traced back to the biopanning process on the one hand, or the
complexity of the NoVLPs as a target on the other hand, and will be discussed in the
following section.
As described in section 2.4.1, numerous crucial biopanning parameters - depending on
the chosen target - determine the success or failure of a selection. Although all sub-steps
of the biopanning experiments - chromatopanning, infection of bacteria with phages,
packaging of phagemid DNA into phage particles, purification of phages, and finally
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determination of phage concentration for each round - were processed smoothly, the
successful selection could only be tested after finishing the whole procedure, which
was the time-limiting factor of this work. The high risk of allocating target-unrelated
phages to binders, as described by Vodnik et al. [96], could finally be overcome in this
thesis by processing only motifs obtained from NGS which were highly enriched with
respect to the original library and the negative panning. Nevertheless, several parameters
remain which could be optimized in a future biopanning against norovirus. In this thesis,
biopanning was performed in solution, followed by a chromatographic recovery process,
and NoVLPs were immobilized either specifically using their poly-histidin-tag for affinity
chromatography (round 1), or unspecifically using ion exchange chromatography (round 2
and 3). Regarding the presentation of the target, chromatography offers several advantages
over standard biopanning selections, as explained in section 2.4.1, and generally specific
immobilisation is more favourable than unspecific adsorption [81, 104]. Nevertheless, the
sequences enriched by chromatographic biopanning were dominated by histidine as a
consequence of the used nickel-chelated column. Although these sequences could finally
be excluded by means of LibDB, a future biopannig experiment could start with ion
exchange chromatography, since the first round might be the most important one, and
be followed by affinity chromatography. Alternatively, a different immobilisation method
like standard solid-phase biopanning could be used in one of the biopanning rounds.
Cosmix-plexing R© was implemented into the biopanning process as one of the key features.
It enhances the variability inside the enriched peptide sequences, and thus the chance to
identify high affinity binders [97]. For a better understanding of this process with respect
to the norovirus biopanning, it would be useful to perform a third round of selection
without cosmix-plexing R©, based on the existing round 2. Then, the influence of this
recombination technique could be studied by comparing the NGS data with and without
cosmix-plexing R©. With regard to the obtained motif enrichments, it would additionally
be useful to carry out a fourth round of panning based on the present third round
PA6_R3+NP. Here, duration of washing could be extended to increase the stringency.
Consideration should also be given to the negative selection, which could be implemented
before every biopanning round in a new selection, at least starting from round 2, to
enhance the chance of selecting target-related phages.
In case these adaptions would not result in specific norovirus binders, one has to take
into account the possibility that the used ENTE1 library does not include any highly
affine norovirus binders, or that the used NoVLPs do not meet the requirements for a
consistent target sample. At least their inconsistent behaviour during chromatography
would fit into that context, and would be worth to be examined in more detail prior to
further biopanning experiments.
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Up to now, the only work dealing with norovirus binding peptides was published by the
group of Timothy Palzkill, Baylor College of Medicine, USA, at the time the biopanning
experiments of this thesis were performed. His group also identified single-chain antibodies
against noroviruses [68], and was involved in characterization studies about monoclonal
antibodies [144]. For biopanning, they used the commercially available Ph.D-12 phage
display library (New England BioLabs), and a standard solid phase biopanning proce-
dure. One of their enriched phage clones, presenting five peptides with the sequence
LPSWYLAYQKII, was able to bind to NoVLPs as well as to noroviruses in stool samples
with a detection limit similar to a commercially used monoclonal antibody [75]. They
showed that this phage clone can bind to the P domain, but not to the S domain. The
isolated peptide was also able to bind to NoVLPs. Other phage displayed peptides with
the same enriched motif SW, or the extended YRSW motif, showed a weaker affinity to
NoVLPs, and no binding to the purified P domain [75], indicating that the full length
peptide is required for binding.
In this thesis, tryptophan (W) also played a dominant role in the enriched motifs listed
in Table 4.6. Although this special motif YRSW was not enriched, variations of the
motif, as YCWR, KRWW, WKWR, KWRP, KRWL, YWRI, or RYSW could be found
(enrichment relative to the ENTE1 library and to the negative panning ≥ 0.3). What
they have in common is the combination of one or two positively charged amino acids (K,
R) with W. These results are in good agreement to the findings of the Palzkill group [75].
Due to its dicyclic, aromatic indole side chain, W might likely be able to participate in
the binding to noroviruses at the same binding sites which are assigned to histo-blood
group antigens (HBGAs), as explained in section 2.2.4. The potential interaction between
these carbohydrates and norovirus P-domain dimers was visualized by Tan et al., and is
shown in Fig. 4.9. Several amino acids of the outermost norovirus capsid are in direct
contact to the oligosaccharids by means of a hydrogen-bonding network, or indirectly
required to retain the structural integrity of the binding pocket [145]. W and potentially
also F and Y with their aromatic side chains might be able to replace the carbohydrate
at this binding interface.
Thus, selected sequences enriched during biopanning, which contain the motifs RWN,
KFW, or FAT, and meet the particular enriched motif fingerprint, would be potential
candidates for prospective norovirus binding assays.
To conclude, this chapter presented one of the first studies on a biopanning selection based
on chromatography, with the focus on norovirus like particles as target molecules. Chro-
matographic conditions were optimized for a binding of NoVLPs to the chromatographic
column, but a non-binding of bacteriophages. Three rounds of biopanning were performed,
with a cosmix-plexing R© step after the second round for a recombination of the enriched
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Figure 4.9: Schematic representation of the interaction between the norovirus capsid (GII.4)
and HBGAs (here: type B-trisaccharide) by Tan et al. [145]. The norovirus P-domain dimer
is visualized be coloured amino acids in the background. The three saccharides of the HBGA
are indicated as 1 to 3, with carbon and oxygen atoms colored in green and red. The star
symbol shows the junction to the remaining part of the HBGA.
peptide sequences. Two sequences of this chromatopanning I were tested in ELISAs,
but a specific binding to NoVLPs could not be found. Therefore, chromatopanning II
included a negative selection before the third round. All experiments were analysed
using next-generation sequencing. The combination of this up-to-date method of high-
throughput sequencing with the LibDB software offered new opportunities of sequence
and motif analysis. As presented in this thesis, all enriched peptides could be sequenced,
instead of a limitation to only 10 to 100 randomly chosen phage clones, as it is the case
when using standard Sanger sequencing. Furthermore, all theoretically occurring motifs
(160,000 for 4-mer motifs) could be evaluated and compared between different runs, and
with respect to their expected frequency or the original library. A special feature of the
LibDB software, which was tested in this thesis, was the motif neighbourhood analysis,
generating a characteristic fingerprint for each motif in a particular selection.
Even though the studies presented here did not result in the experimental verification
of highly affine norovirus binding peptides, promising motifs were identified to sort out
peptides for future binding tests. Furthermore, improved strategies were proposed for
upcoming biopanning experiments against NoVLPs. Last but not least, this thesis showed
the potential of the presented NGS-based evaluation methods for biopanning selections
in general.
5 Towards Phage Microfluidic Array
Up to now only few studies have investigated the use of bacteriophages in microarray
applications, as introduced in section 2.5.2 [133–135]. One focus of this work was to
demonstrate at the proof of concept level the possibility to use phage arrays as binding
assays for testing phage-analyte interactions. For this purpose, the printing of phages
in a non-contact mode should be established, and a protocol for phage detection as a
control phage array should be developed. Finally, this array should be combined with a
microfluidic system for a prospective automation of the assay. This chapter will describe
and discuss all phage array related results.
5.1 High resolution microscopy of M13 phages
M13 phages were studied by AFM prior to phage-based microarray experiments. Fig. 5.1
A shows filamentous phage particles immobilised on an 3-aminopropyltriethoxysilane
(APTES)-functionalised silicon dioxide surface. In accordance with literature [85], they
have a filamentous structure with a length of appr. 1µm. At a concentration of 3×1010
phages/ml, they appear to lie flatly and separately on the surface with partial overlap.
Immobilisation of phages on a non-functionalised silicon dioxide surfaces was also possible
(Fig. 5.1 B). Here, the same concentration of phages again resulted in flatly oriented
particles. Interestingly, they appear to interact with each other, forming bundles of
phages and creating a network. The height of these bundles was measured to be 2-times
larger compared to the height of single phage particles in both images, implementing
that phages lie one upon the other (see height profiles in Fig. 5.1).
An intermediate pH was chosen for the experiments, as phages were suspended in TBS
buffer pH 7.5, and washing was performed with deionized water (pH 5 to 6). Since M13
phages have a pI of 4.3 [118], they are negatively charged at higher pH due to the free
carboxylic acids groups of the N-terminal amino acids of the major coat protein pVIII,
and are well-adsorbing on a positively charged surface as the APTES-functionalised
one [146]. On a negatively charged surface as the blank silicon dioxide (pI of 1.9), they
might preliminary bind due to the positively charged pVI coat proteins (pI 9.5) on one
end of the phage particles. This local binding might result in the possibility of phage
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A B C
Figure 5.1: High resolution microscopy imaging of 3×1010 M13 phages/ml. (A) Atomic force
microscopy on (A) APTES-functionalised surface, and (B) unfunctionalised silicon dioxide
surface. An exemplary height profile along the blue line is shown below. (C) Scanning
electron microscopy on silicon dioxide surface to visualize the possibility of phage alignment.
alignment due to shear forces in the direction of washing and blowing [146], an effect which
could also be observed in this theses on the silicon dioxide surface by scanning electron
microscopy (Fig. 5.1 C). The observation of bundle formation, visible in Fig. 5.1 B, is also
in good agreement to the studies of Jeon et al., and might be explained by the interaction
between locally positively (pVI, pIX) and negatively (pIII, pVII) charged coat proteins of
different phages, facilitated due to the repelling effect between both negatively charged
phages and silicon dioxide surface [146].
A successful immobilisation of phages was observed on a positively as well as on a
negatively charged surface, whereas characteristic differences were detected between both
surfaces in terms of phage orientation, caused by the differently charged phage coat
proteins. In contrast to the positively charged surface, the negatively charged one induced
phages to form bundles and networks. It also opened the possibility of controllable phage
alignment, which is important for various applications, including nanoelectronics and
oriented cell growth [122, 147, 148]. The simple method of alignment, studied by Jeon et
al. and in this thesis, might be useful for future phage applications. However, further
experiments would have to be performed to analyse pH and surface charge dependency
in more detail. To conclude, high microscopy imaging of M13 phages could verify their
integrity and their ability to be immobilised on negatively and positively charged surfaces.
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5.2 Spotting of fluorescently labeled phages
As a prerequisite for a phage-based microarray, phages have to be attached onto a surface
in a distinct pattern. To visualize the phages, they can be labeled by fluorescein isothio-
cyanate (FITC). After literature review [126, 149], a labeling protocol was established
as described in section 3.5.1. For immobilisation, the Nano-Plotter
TM
micropipetting
system was chosen, providing a non-contact printing technique by a piezoelectric pipetting
tip. Different phage concentrations were spotted onto an APDMES-functionalised glass
surface (see 3.5.2) in one array (see 3.5.3), and visualized by fluorescence microscopy.
Figure 5.2: Fluorescence microscopy image to confirm the immobilisation of fluorescently
labeled phages by non-contact printing on an APDMES-functionalised glass surface.
A) 1×1012 phages/ml, B) 1×1013 phages/ml, C) Signal-to-background ratio of the fluorescence
intensity of the FITC-labeled phage spots. Horizontal grey line represents the background
signal set to 1.
Figure 5.2 shows the generated spots with 1×1012 phages/ml (A), and 1×1013 phages/ml (B).
Since the applied piezoelectric pipetting tip, the pico-tip, generated droplets of around
70 - 80 pl, one spot corresponded to an absolute number of 1×105 and 1×106 phages,
respectively.
Clearly defined spots were produced as expected, with a diameter of around 80µm on the
APDMES-functionalised surface. They show a locally increased signal on the borderline.
This boundary effect is more pronounced for the higher phage concentration, and might
be explained by the preferred accumulation of phages on the borderline during drying of
the spots. Since phages generating this borderline were also part of the appropriate phage
number, boundaries were included during analysis. Background signal was extremely
low, since the setup did not include any washing steps. The fluorescence intensity was
dependent on the phage concentration, with a signal-to-background-ratio (SBR) of 6.1
for 1×1012 phages/ml, and 10.1 for 1×1013 phages/ml, respectively (Fig. 5.2 C).
Summarising, non-contact printing of filamentous phages in a pre-defined pattern could
be achieved, and successful fluorescence labeling of phages was verified simultaneously.
76 5 Towards Phage Microfluidic Array
5.3 Development of a positive control for phage
microarray
The aim was then to establish a microarray related detection of unlabeled phages based
on a phage-antibody interaction. For this purpose, the concept of hybridization was
initially tested in an enzyme-linked immunosorbent assay (ELISA), and subsequently
transferred to the array format.
5.3.1 ELISA
In the ELISA experiments, the influence of the phage concentration on the signal intensity
was studied. Therefore series of different phage concentrations were immobilized in 96-
well plates, and subsequently detected by a primary mouse anti-phage antibody and a
secondary horseradish peroxidase (HRP)-labeled anti-mouse antibody (see section 3.3 for
details). BSA was used for blocking and as negative control. Two different anti-phage
antibodies, both relevant for phage display, were tested: an anti-pVIII antibody, specific
for the major coat protein pVIII, and an anti-pIII antibody, binding to the minor coat
protein pIII.
Fig. 5.3 shows the results for the anti-pVIII antibody. A concentration of 1×107 phages/ml
(corresponding to 5×105 phages per well) was determined as detection threshold, giving a
significantly enhanced signal relative to BSA. With increasing phage concentration, pro-
gressively higher absorption values were measured. For 1×1011 phages/ml (corresponding
to 5×109 phages per well), the signal was around 23 times higher relative to BSA. For
1×1010 phages/ml, similar or only slightly lower values were achieved in the individual
measurements. This might reflect the saturation of the well with phages at concentrations
between 1×1010 and 1011 phages/ml, or it indicates the optimal phage concentration for
primary antibody binding. Here, it would be interesting to test if even higher phage
concentrations would cause a reduced antibody binding efficiency.
Variations within the individual experiment were minimal, but deviations between differ-
ent runs were relatively high in this thesis, indicated by quite dominant error bars. This
is presumably caused by the use of different phage batches, for which the determination
of the absolute concentration of phages has to be understood as an estimation. In a
recent study, Lang et al. developed a phage pVIII-based ELISA for prostate-specific
antigen detection. They also observed a saturation of the signal at 1×1011 phages/ml
when carrying out a blocking step during ELISA [150].
Additionally, an antibody specific for pIII, the minor coat protein responsible for present-
ing the randomized peptide in phage display applications, was tested as well (Fig. 5.4).
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Figure 5.3: Absorption signal relative to BSA for the binding of an anti-pVIII antibody to
different phage concentrations, tested by ELISA. 1 mg/ml BSA was used for blocking, anti-
pVIII antibody was diluted 1:500, secondary antibody 1:6000. Values are based on three
independent experiments performed in duplicates, with the exception of only two independent
experiments for 106 and 107 phages/ml. Highest phage concentration without anti-pVIII
antibody, and BSA instead of phages were used as negative controls, indicated as white
columns.
Here, a 4-fold higher concentration of the secondary antibody had to be used compared
to the pVIII-related experiments to obtain results within the detection range. The main
reason for this fact are the very different copy numbers on a single phage particle: whereas
about 2800 copies of pVIII form one particle, only 5 copies of pIII can be found [85]. So
fewer primary antibodies can bind to pIII than to pVIII on a phage, resulting in a lower
signal amplification by the secondary antibody.
A significantly increased signal relative to BSA could be achieved for phage concentra-
tions of 108 phages/ml and higher. Surprisingly, highest absorption was measured for
1×1010 phages/ml. A concentration of 1×1011 phages/ml instead resulted in a decreased
signal, suggesting that the phage ends presenting pIII are better accessible for antibody
binding at the lower phage concentrations.
As learnt from the AFM studies (section 5.1), positively charged phage coat proteins
pVI and pIX might interact with negatively charged coat proteins pIII and pVII at
neutral pH, with pIII being the by far most negatively charged protein (net charge -27
at pH 7) [146]. Whereas adsorption of the phages to the ELISA well plate preliminary
occur due to hydrophilic and hydrophobic binding sites provided by the Nunc MaxiSorp R©
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Figure 5.4: Absorption signal relative to BSA for the binding of an anti-pIII antibody to
different phage concentrations, tested by ELISA. 1 mg/ml BSA was used for blocking, both
anti-pIII antibody and secondary antibody were set to 1:500. Values are based on two
independent experiments performed in duplicates. Highest phage concentration without
anti-pIII antibody, and BSA instead of phages were used as negative controls, indicated as
white columns.
surface of the plate, interactions between phage ends will play an increasing role with
rising phage concentration. The results obtained in this study indicate that at a phage
concentration between 1×1010 and 1×1011/ml a threshold might be reached, at which
the network of phages becomes so tight that most of the pIII proteins interact with
positively charged coat proteins of other phages and are no longer accessible for antibody
binding. In the AFM experiments, a concentration of 3×1010 phages/ml resulted in a
relatively loose network of phages in which phage ends appeared to be separated from
each other (see section 5.1). With respect to the larger volume of phage suspension used
in ELISA relative to the single droplet applied for AFM analysis, during ELISA more
phages might had the possibility to attach to the surface at the same phage concentration,
suggesting that tight networks of phages might likely appear at the well surface at phage
concentrations higher than 3×1010 phages/ml. However, since AFM and ELISA protocols
were very different, this can only be considered as a presumption.
In conclusion, specific and concentration-dependent binding to the phage coat proteins
could be verified for both antibodies by ELISA. In the given setups, detection limits of
1×107 and 1×108 phages/ml were determined for the anti-pVIII and anti-pIII antibody,
respectively. The anti-pVIII antibody resulted in a signal proportional to the phage
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concentration, striving to a saturation of the signal at 1011 phages/ml. The anti-pIII
antibody also showed a signal proportional to the phage concentration, but maximal
absorbance was achieved at 1010 phages/ml, and 1011 phages/ml caused a signal similar
to that of 108 phages/ml. In good agreement to the AFM studies, these observations
suggest that starting from a concentration between 1010 and 1011 phages/ml the surface
of the wells might be saturated with phages, resulting in no further increase of the
anti-pVIII antibody binding sites, and even a decrease in the accessibility of pIII proteins
for anti-pIII antibody interactions.
5.3.2 Phage array
A protocol for the phage array technique was developed, and is described in Materials
and Methods 3.5.4. Briefly, after non-contact printing of phages, or BSA as negative
control, hybridization was performed based on the mouse anti-pVIII-antibody used in
ELISA, and a DyLight
TM
488-labeled secondary anti-mouse antibody. Phage arrays were
then analysed by fluorescence microscopy.
In the following, several experiments will be presented which were conducted to optimize
the protocol with regard to hybridization and washing conditions, including the antibody
concentrations, as well as to assess the robustness of the assay setup. In all experiments,
printed phage spots had clearly defined borders and a higher signal intensity than the
background. By contrast, BSA spots had the same signal intensity as the background
or appeared even darker. This might be explained by the high local concentration of
BSA within the spots due to the nanoplotting process relative to the surrounding area,
which was only incubated with BSA during blocking. Characteristic fluorescence images
showing two phage spots (left) and two BSA spots (right) are presented in Fig. 5.5 for all
three tested phage concentrations and varying secondary antibody dilutions. Primary
anti-pVIII antibody dilution was kept constant at 1:500. Samples A to C were treated
with a secondary antibody dilution of 1:2500, samples D to F with a dilution of 1:200. A
and D show the lowest phage concentration tested with 2.5×1011/ml, B and E 1×1012/ml,
and C and F 4×1012/ml. Relation between secondary antibody concentration and signal
intensity can be detected by eye, since the higher antibody concentration results in
much brighter spots. Relation of phage concentration and signal intensity is not that
apparent, but was measured as described in 3.5.6 and plotted in Fig. 5.6. Spots of
2.5×1011 phages/ml already have a SBR of 1.3 and 1.9 for a 1:2500 and 1:200 secondary
antibody dilution, respectively. At this low phage concentration, one spot is generated
by only 2×104 phage particles (assuming a spot volume of 80 pl), but they were reliably
detectable. For the lower secondary antibody concentration (1:2500 dilution), a maximal
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Figure 5.5: Fluorescence microscopy images showing a series of different phage concentrations
in a phage array, incubated with anti-pVIII antibody (1:500), and hybridized with secondary
DyLight
TM
488-labeled antibody (A-C: 1:2500, D-F: 1:200). A+D: 2.5×1011 phages/ml, B+E:
1×1012 phages/ml C+F: 4×1012 phages/ml. White circles indicate the location of BSA spots.
Scale bars represent 100 µm.
SBR of 1.6 was determined for 4×1012 phages/ml, compared to 3.1 for 1:200. Thus,
for both concentration series, an increase of signal proportional to phage concentration
could be observed, but the increase was more pronounced for the 1:200 dilution. Further
experiments showed that a decrease in the primary anti-pVIII antibody dilution to 1:100
did not alter the SBR compared to 1:500, suggesting that a dilution of 1:500 was sufficient
for binding all accessible pVIII molecules. On the other hand, a further dilution of
the secondary antibody to 1:5000 resulted in a SBR of only 1.1 to 1.2, and no further
increase with rising phage concentration (data not shown). This indicates that at this
low antibody concentration the amount of antibodies might be the limiting factor for
signal generation, and not the availability of primary antibodies or phages. Higher phage
concentrations might not cause a signal increase, since already at a concentration of
2.5×1011 phages/ml not all accessible primary antibodies can be bound by secondary
antibodies.
An important research issue was the robustness of the assay setup, and based on that,
the reproducibility. Parameters essential for a successful phage array were figured out.
Starting from the nanoplotting, a fresh functionalisation was required. Thus, spotting
had to be performed directly after finishing the functionalisation process. Regarding
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Figure 5.6: Signal-to-background ratio of the fluorescence intensity plotted against phage
concentration for two secondary antibody dilutions. Dilution of primary antibody was 1:500.
Data points are connected by lines to guide the eye. Horizontal grey line represents the
background signal set to 1.
the nanoplotting, the highest analysed phage concentrations of 4×1012/ml could not be
printed in a few cases using the pico-tip as pipette. In order to avoid this, the nano-tip -
pipetting volumes of around 0.4 nl - would be an alternative. Disadvantage here would
be the consequential larger spot size.
As shown in Fig. 5.5, low phage concentrations resulted in a more or less homogenous
fluorescence distribution within the spot and a low spot-to-spot variation. Accumulation
of phages could also be found for 2.5×1011 phages/ml at high secondary antibody
concentration, but was more pronounced with increasing phage concentration. Ring
formation occurs when droplets of a liquid containing solid particles evaporate [151].
This phenomenon is caused by the capillary flow inside the droplet. Since the contact
line of the drying droplet is pinned to the surface, liquid evaporating at the outer edge
has to be replenished by liquid from the interior, causing the transport of particles to
the outer edge, as visualized in Fig. 5.7 [152]. Since ring formation is dependent on
particle size and number [153], as well as on surface functional groups [154], it is likely
less pronounced for smaller molecules like aptamers. Nevertheless, accumulation at the
outer ring was also described for microarrays by Eisen and Braun [155]. They assume
that a longer rehydration after printing would be helpful to generate more homogenous
spots. Nevertheless, they stated that those arrays can still be analysed. However, this
issue should be considered in future applications and might be overcome by the addition
of surfactant [156].
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Figure 5.7: Ring formation by capillary flow. A) Cross section through a droplet slowly drying
on a surface. If there were no flow, the droplet would shrink (top), but since the contact
line is pinned to the surface, liquid must flow outward to prevent shrinkage [152, with minor
adaptions], resulting in B) the transport of particles to the outer edge of the droplet [156,
with minor adaptions].
High phage concentrations heightened the risk of leaching of the spots, sometimes resulting
in completely washed out spots where only the outer ring remained. One explanation
would be, that at the given phage concentrations each phage can interact with several
other phages, forming a tight network which is more proned to be washed off completely
if washing conditions were too stringent. Altogether, the array setup has to be rated
as relatively susceptible to the applied washing conditions. Automation of the washing
procedure by means of a microarray washing station, or the integration of the phage
array into a microfluidic system, might improve the robustness and reproducibility of the
assay.
Fig. 5.8 shows the SBR of three independent experiments with a primary antibody
dilution of 1:500, and a secondary antibody dilution of 1:2500. Whereas the general trend
of an enhanced signal for higher phage concentrations remained, the average SBR was
not higher for 1×1012 relative to 2.5×1011, and standard deviations were relatively high.
Besides the sensibility for washing and hybridization conditions, different phage batches
might result in varying phage concentrations, and hence varying signal intensities, like in
ELISA.
In a future application, M13 phages could be used which display peptides specific to a
certain target. In the simplest case, targets would be different antibodies in a patient
serum, and binding would be detected by a secondary antibody. This binding scheme
of an analytical microarray was applied by Arnaud et al. [133] and Cekaite et al. [134].
A parallel array could be hybridized using the anti-pVIII antibody as performed in
this thesis, allowing the correlation between this phage control array and the test array.
Cekaite et al. used mouse antiserum against wild type phage capsid proteins for the
control array and observed a clear positive correlation between intensities of control and
test spots. This concept thus allows the quantitative comparison of the binding affinity of
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Figure 5.8: Signal-to-background ratio of the fluorescence intensity plotted against phage
concentration (primary antibody 1:500, secondary antibody 1:2500). Values are based on
three independent experiments with the exception of only two independent experiments for
4×1012 phages/ml. Data points are connected by lines to guide the eye. Horizontal grey line
represents the BSA background signal set to 1.
different phage batches, since batch-to-batch variances can be overcome by normalizing
the fluorescence intensity of the test array spot to the corresponding phage array signal.
Another important issue was the comparability of images, even with the same settings
and exposure times, since contrast was automatically re-adjusted to a certain extent. This
is unproblematic for images of the same series, and calculation of signal-to-background
ratios reasonably circumvent the problem for comparing different experiments. However,
this has to be kept in mind during analysis. For an actually relative quantification, spots
of a positive control (e.g. immobilized mouse antibody) would have to be spotted and
evaluated on the same image as the phage spots, allowing a quantification relative to
positive and negative control. However, Cekaite et al. could not find a definite correlation
between signal intensities of positive controls and the corresponding phage array [134].
Phages revealed the ability to attach to a freshly plasma treated, unfunctionalised silicon
dioxide glass surface (Fig. 5.9), fitting to the observations of the AFM studies in 5.1. Here,
diameter of spots was around 180 µm (B). In comparison, nanoplotting on APDMES-
functionalised surfaces resulted in smaller spots with a diameter of around 80 µm (A), due
to the higher contact angle on aminosilane surfaces relative to the plasma-treated glass
surface [157]. Mean signal intensities were the same in both samples for 1×1012 phages/ml,
with a signal-to-background-ratio of 1.3. Considering that, due to the bigger diameter,
spots on the unfunctionalised surface have an at least 4 times larger area relative to the
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Figure 5.9: Fluorescence microscopy images showing spots of 1×1012 phages/ml, incubated
with anti-pVIII antibody (1:500), and hybridized with secondary DyLight
TM
488-labeled
antibody, on A) APDMES-functionalised surface, and B) unfunctionalised surface. Phage
spots are encircled with white dotted lines, circles with continous white lines indicate the
location of BSA spots. Scale bars represent 100 µm.
ones on the APDMES surface, phages might have had the possibility of spreading instead
of forming a thick multilayer. As stated above, higher phage concentrations resulted
in a further SBR increase on functionalised surfaces. However, a clear trend could not
be found for unfunctionalised surfaces, as an increase was not observed each time. One
possible explanation would be a stronger sensitivity to the particular washing conditions.
A slightly more stringent washing might have a stronger effect on the unfunctionalised
surface relative to the functionalised one, since phages probably only bind locally by
means of their positively charged coat proteins pVI and pIX, in contrast to the binding
of the major coat protein pVIII to the positively charged APDMES on the functionalised
surface. Here, further investigations to phage arrays on an unfunctionalised surface would
be necessary.
In literature, phages were spotted on charged surfaces like gamma aminopropyl silane
slides [134], epoxy silane slides [135], or nitrocellulose membranes [133]. The APDMES
functionalisation applied in this thesis most closely resembles the gamma aminopropyl
silane, as both provide free amino groups for binding. In all published studies, contact
printing was used for spotting phages, resulting in spot diameters of 100 µm [135] to
250 µm [134]. This thesis shows for the first time that non-contact printing of filamentous
phages is also possible. Advantages are a higher reproducibility of spot size, smaller spots,
and the possibility to print any arbitrary spot pattern, which is especially useful for the
integration into a microfluidic system.
Regarding the pVIII antibody, the applied ELISA protocol resulted in a detection
threshold of 5×105 phages per well. In the phage array, signals from spots with 2×104
phages were clearly detected, and detection threshold might be even lower, since smaller
concentrations were not tested. Thus, the sensitivity of the phage array can be rated to be
higher than that of ELISA with respect to the anti-pVIII antibody, while reducing phage
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and antibody consumption at the same time. Nevertheless, for the anti-pIII antibody a
comparision has not yet been made.
In summary, the experiments have shown that the setup could successfully visualize the
specific interaction between M13 phages and anti-pVIII antibodies on unfunctionalised
and APDMES-functionalised glass surfaces. On the functionalised surface, the results
indicate a signal-to-background ratio proportional to the phage concentration for the
tested primary anti-pVIII antibody dilutions between 1:100 and 1:500, and secondary
antibody dilutions between 1:200 and 1:2500, but not for 1:5000. Regarding the absolute
number of phages, with the applied protocols the detection threshold was at least one
order of magnitude lower than that measured by ELISA. Further experiments would be
helpful to optimize the technique in terms of reproducibility, and to transfer the protocol
to a given application.
5.4 Integration to microfluidics
One option of optimization could be provided by combining the phage array with microflu-
idics, aiming at a strengthened automation and based on that, an increased reproducibility,
as well as shorter hybridization times and an ever lower antibody consumption.
Microfluidic setup was based on a polydimethylsiloxane (PDMS)-made channel attached
on top of the phage array for performing all liquid handling steps necessary for hy-
bridisation (see Materials and Methods 3.5.7 for details). Fig. 5.10 shows a schematic
representation of the microfluidic setup. It includes three syringes for wash buffer and
antibody solutions, connected to the channel by tubes and a 4-way intersection. Liquid
flow was controlled by a syringe pump, and in front of the channel by a valve. The
channel was directly placed on top of the phage spots. Glass slide with aligned PDMS
block containing the channel as well as the inlet and outlet tube can be seen on the photo
image.
Most challenging part of the whole setup was the alignment and plasma-activated bonding
of channel and array. On the one hand, it was essential to generate a waterproof channel
without any leaking. This was only possible if both parts had been plasma activated
before. Regarding the phage array, activation necessarily has to be performed before
spotting, otherwise plasma would have destructed the biological material. This had
two consequences: Firstly, functionalisation of the glass slide before spotting was not
possible in the microfluidic setup - before plasma activation functionalisation would have
been destructed during plasma, after it, plasma activation would not have remained
during functionalisation. Secondly, time for spotting had to be minimized so that plasma
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Figure 5.10: Integration of the phage array into a microfluidic system. The setup consists of
syringes for providing wash buffer and antibody solutions, controlled by a syringe pump
(schematically represented by the red block). Syringes were connected with tubes (blue lines)
to the channel system, which was directly aligned and fixated to the 24×50 mm glass slide on
which the phage array was printed. Channel and array are presented in side and top view.
The photo shows the PDMS-made channel, consisting of PDMS block and glass slide with
printed array, and its connections to the microfluidic setup.
activation would be still sufficiently strong enough for bonding. On the other hand,
collapse of the channel, 500µm wide and less than 30µm high, had to be avoided. So
bonding had to be performed gently, without any pressure. Hybridization was performed
using the microfluidic system as explained in Materials and Methods 3.5.7.
Fig. 5.11 shows a fluorescence image of the phage spots in the channel after antibody
staining and washing. Here, spots of 2.5×1011 phages/ml appeared homogenously stained,
and resulted in a SBR of 3.3 ± 0.3 for a primary antibody dilution of 1:200 and a secondary
antibody dilution of 1:1000, which is much higher than all SBRs determined for the
static array. However, these results cannot be directly compared, since differing antibody
dilutions were applied. Nevertheless, it was found that an increase of primary antibody
concentration have not had an effect on the SBR in the static array, and secondary
antibody concentration here was situated between the tested dilutions in the static array.
So the measured SBR can be considered as higher than in a corresponding static array
(1.9 ± 0.1 for 2.5×1011 phages/ml, primary antibody 1:500, secondary antibody 1:200).
Regarding the static array on an unfunctionalised surface, a SBR of only 1.3 was measured
for 2.5×1011 phages/ml, primary antibody 1:100, secondary antibody 1:2000. The higher
SBR in the dynamic array was probably caused by the permanent flow of liquid over
the spots. Thus, new antibodies were delivered during the whole incubation time and
could bind to their target, whereas in a static array only diffusion provides exchange of
molecules near the surface.
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Figure 5.11: Fluorescence microscopy image showing spots with 2.5×1011 phages/ml in a
microfluidic channel. Detection was based on binding of primary anti-pVIII antibody (1:200),
and secondary DyLight
TM
488-labeled antibody (1:1000). Antibody concentrations in dynamic
array are not equivalent to same concentrations in static array. White circles indicate the
location of BSA spots. Scale bar represents 100 µm.
Spots were stained not only in the channel, but also directly beyond the borderline of
the PDMS channel wall. Spots nearby, but outside the channel, were not stained. BSA
spots showed again a lower fluorescence signal than the background.
Whereas 2.5×1011 phages/ml could be successfully detected, spots of higher concentrations
(5×1011 and 1×1012 phages/ml) were virtually completely washed out, as exemplarily
shown in Fig. 5.12. The spots inside the channel showed almost no fluorescence signal,
but scraps of highly fluorescent material, presumably of phage aggregates, could be
found downstream directly adjacent to these spots, and sometimes even further on
downstream. These observations provided some more valuable information regarding the
spot morphology. Generally, the center of the spot showed a high fluorescent intensity,
encircled by a ring of lower intensity, and finally the highly fluorescent borderline. This
spot pattern is in good agreement with known dry-out characteristics of nanoparticle-
containing droplets, as already described above [153, 158]. More importantly, in the
microfluidic channel, the whole area of the spots with high phage concentration appeared
to be turned down in downstream direction, or even folded up. These results shed new
light on the observations made in AFM, ELISA, and the static array, indicating that
above a certain threshold concentration phages form such a tightly connected layer, that
it might be torn off as a whole if affinity between the phage particles was stronger than
the binding of the individual phages to the surface. Here, on the unfunctionalised surface,
this threshold concentration was between 2.5×1011 and 5×1011 phages/ml, as the lower
concentration resulted in stable spots, whereas the higher concentrated spots had an
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increased risk to be washed off under the applied microfluidic conditions. Nevertheless,
the SBR of the washed off high-concentration material (e.g. arrow 1 in Fig. 5.12) was
higher than the SBR of intact spots with 2.5×1011 phages/ml, with 4.2 ± 0.2 for 5×1011,
and 4.5 ± 0.1 for 1×1012 phages/ml.
Figure 5.12: Fluorescence microscopy image (A) and schematic representation (B) to visualize
some characteristics of washed out phage spots in the microfluidic channel (1×1012 phages/ml),
indicating the formation of a tightly connected phage layer within the spot, which could be
turned down (arrow 1), and even formed a double layer (arrow 2). White circles indicate the
location of spots (dotted line: phage spots, continuous line: BSA spots). Scale bar represents
100 µm.
This drawback of spot instability might be overcome using concentrations of 2.5×1011
phages/ml or lower, or an optimised microfluidic protocol with lower flow velocities.
Apart from that, integrating the phage array into microfluidics brought several benefits:
it allowed a higher level of automation, and due to the dynamic delivery of antibodies
a higher SBR. It also opened the possibility of online monitoring, as more than one
washing step could be performed after second antibody incubation, and spots could be
simultaneously observed by fluorescence microscopy. Here, online monitoring was used
to implement a second more stringent wash with a flow velocity of 4 ml/h instead of
1 ml/h. No major changes relative to the images after the first washing step (Fig. 5.11)
were found. Highly fluorescent material did not change its location, and the SBR was in
the same range, intimating that destruction of phage spots happened earlier during the
microfluidic protocol, probably already at the very first step of offline blocking. Since
blocking was performed manually, flow velocity might have been higher than 1 ml/h, even
if minimal possible pressure had been applied to the syringe. This might be overcome
using a setup in which an additional automated pump can be implemented for providing
the blocking solution.
Another advantage of integrating the phage array into microfluidics is the opportunity of
parallelisation, like testing varying antibody concentrations in parallel channels at the
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same time. A potential setup to produce a concentration gradient within the microfluidic
channel system was already tested, and is explained in the Supplementaries A.3.
In summary, a proof-of-concept was shown for the successful integration of the phage
array into a microfluidic system. SBR measurements gave promising results, as a
higher signal-to-background ratio was determined with a simultaneous decrease of total
antibody consumption in comparison to the static phage array. Since microfluidics could
only be combined with phage arrays on unfunctionalised surfaces, concentrations of
2.5×1011 phages/ml and lower should be tested in future studies, as higher concentrations
resulted in an increased risk of spot instability. The microfluidic protocol might be further
optimised with respect to antibody concentrations and flow rates, and validated in terms
of reproducibility. Then, integration of the array into microfluidics offers the opportunity
of online monitoring, automation, and parallelisation.

6 Summary and Outlook
Phage display was the central issue of this thesis. On the one hand, this technique
was used to perform biopanning experiments to identify recognition elements against
noroviruses, the major agent of nonbacterial gastroenteritis worldwide. Selections were
based on chromatography, and combined with a next-generation sequencing analysis. On
the other hand, a proof-of-concept was developed for a phage microfluidic array as a
novel assay to study the interaction of phages with other molecules.
Norovirus like particles (NoVLPs) were used as target molecules for the biopanning
selections. Initially, their integrity was verified by atomic force microscopy. With
a typical diameter of 20 to 30 nm, most particles were slightly smaller than the size
described in literature, which could be explained either by strain-specific sizes, as observed
by De Rougemont et al. [46], or by the formation of capsids consisting of only 60 or 80
VP1 proteins, instead of 180 as usually.
Biopanning selections were planned and performed in cooperation with the Ligand
Development Unit (M. Szardenings) of the Fraunhofer Institute for Cell Therapy and
Immunology, Leipzig. To carry out biopanning experiments based on chromatography,
initially chromatographic conditions were examined at which NoVLPs could bind to the
column, but phages passed through. Immobilized metal ion affinity chromatography was
used in the first round, whereas round 2 and 3 were based on ion exchange chromatography.
After the second round, the cosmix-plexing R© technique was successfully implemented to
recombine the enriched sequences. Phage pools of round 2 and 3 were processed for next
generation sequencing. This high throughput technique allows the analysis of all selected
phages instead of only a few as it is the case for traditional Sanger sequencing. Analysis
of the most enriched sequences and motifs revealed that histidine was the most frequent
amino acid, most likely due to the chromatographic strategy of the first biopanning round,
which was based on the binding of the histidin-tagged NoVLPs to the Ni2+ charged
chelating groups of the chromatographic column. Motifs were ordered by their enrichment
in round 3 relative to round 2, and two selected sequences as well as a short form of one
of the sequences, and a randomized sequence, were tested as peptides in enzyme-linked
immunosorbent assays. Based on these experiments, both sequences seemed to represent
unspecific binders, as they bound with high affinity to both NoVLPs and background.
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By contrast, the short form and the randomized sequence showed no or only very few
affinity, respectively, to both NoVLPs and background.
Therefore, a further round of biopanning with negative selection was performed, based on
the existing phage pool after cosmix-plexing R©. Round 3 and the negative selection were
both evaluated by next-generation sequencing, and a comprehensive analysis of all runs
was performed using the LibDB software. With this tool, the frequency of all theoretically
possible 160,000 4mer motifs could be determined, and motifs could be sorted by their
enrichment relative to their expected frequency, or to the original ENTE1 library. Based
on this, the difference of the enrichment between biopanning run and negative selection
could be determined for each motif. Motifs which were highly enriched with respect to
the original library as well as to the negative panning could be characterized by their
large proportion of the amino acids W, K, R, N, and F.
A motif fingerprint analysis was exemplarily performed for selected 3mer motifs, since
the motif’s neighbourhood is likely to be of importance for a specific binding to the
target. Of all studied motifs, FAT, RWN, and KWF possessed the fingerprints with the
largest differences with respect to the one of the ENTE1 library. They also showed an
upregulation of the amino acid P in the direct motif neighbourhood, enabling an exposing
of the motif. The dominance of W in the motifs selected in this thesis fits very well to
the results of Rogers et al. [75], who identified a NoVLP binding sequence, and to the
findings of Tan et al., who studied the interaction between noroviruses and their natural
carbohydrate binding partners, the histo-blood group antigens [145]. Here, W might likely
be able to replace the carbohydrate.
In the second part, the basic principle of a phage-based microfluidic array was developed.
Initially, atomic force microscopy was used to study the immobilisation of phages on both
positively and negatively charged surfaces. Whereas phages were separately adsorbing
on the positively charged, APTES-functionalised silicon dioxide surface due to their
negatively charged major coat protein, they formed bundles and networks on the blank,
negatively charged silicon dioxide surface. Here, they might only be able to bind locally
due to their positively charged pVI coat protein on one end, and due to the repelling effect
between both negatively charged surface and phages, interactions between positively and
negatively charged coat proteins of different phages might cause a strongly interconnected
network, as suggested by Jeon et al. [146].
In a next step, this thesis could show that fluorescently labeled phages can be spotted in
a distinct pattern using a non-contact printing technique. In preparation for the phage
array, the interaction between phages and antibodies directed against their major coat
protein pVIII, or their minor coat protein pIII, were studied in an ELISA setup. Both
antibodies showed a concentration dependent binding behaviour with a saturation of
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the signal between 1010 and 1011 phages/ml, indicating that at this concentration no
further phages could bind to the surface. In contrast to the anti-pVIII antibody, for the
anti-pIII antibody the signal was even lower at 1011 phages/ml relative to 1010 phages/ml,
suggesting that the pIII proteins might be even more unattainable for the antibody at
this high phage concentration due to the strong phage network. By transferring the
hybridization protocol of the pVIII-ELISA experiments to the non-contact printed phages,
a protocol for the phage array was developed for an APDMES-functionalised and for a
non-functionalised glass surface.
At the proof-of-concept level, the phage array could also be successfully integrated
into microfluidics, resulting in higher signal-to-background-ratios relative to the static
array. Future studies could optimize flow rates as well as the phage concentration to
lower the risk of spot instability. Using the microfluidic system developed in this thesis,
2.5×1011 phages/ml resulted in stable spots.
This thesis thus identified promising norovirus recognition motifs and characterized their
fingerprints. As an outlook for future research, peptides containing these motifs would
be suitable candidates in binding tests against NoVLPs. In case they don’t show the
expected affinity and specificity, a further biopanning selection against NoVLPs could
be performed with an optimized strategy, as discussed in section 4.4. The availability of
newly produced NoVLPs in assured quality would be a prerequisite for both binding tests
and biopanning experiments. Moreover, the next-generation sequencing-based analysis
tools presented here could be used in biopanning evaluations in general, since they allow a
detailed analysis of all possible amino acid motifs and their fingerprint in the given context.
Regarding the phage array development, the established setup would be especially useful
to study the interaction of pVIII-based display systems with antibodies, or as positive
control for other approaches. Furthermore, the integration of the array into microfluidics
could be optimized as discussed above, thus allowing online monitoring, automation, and
parallelisation of the phage array analysis.
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A.1 Additional materials
Chemicals
Chemical Provider
Acetone VWR
Agar-agar Sigma-Aldrich
Agarose Carl Roth
3-aminopropyldimethylethoxysilane (APDMES) abcr GmbH & Co KG
Ampicillin Carl Roth
Bacto tryptone Fluka
Bovine serum albumin (BSA) Amresco
Dimethyl sulfoxide (DMSO) Merck
Glacial acetic acid Merck
Ethanol VWR
Ethidium bromide Invitrogen
Ethylenediaminetetraacetate (EDTA) Carl Roth
Fluorescein isothiocyanate (FITC) Sigma Aldrich
Imidazole Carl Roth
Isopropanol VWR
Non-fat dry milk Carl Roth
Polyethylene glycol (PEG)-8000 Carl Roth
Potassium chloride (KCl) Carl Roth
Sodium bicarbonate (NaHCO3) Fluka
Sodium carbonate (Na2CO3) Gruessing GmbH
Sodium chloride (NaCl) Carl Roth
Sodium hydrogen phosphate Na2HPO4 Carl Roth
Sulfuric acid VWR
Sylgard 184 silicone elastomer kit (PDMS) Dow Corning
Tetramethylbenzidine (TMB) Sigma-Aldrich
112 A Supplemental Material
Chemical Provider
Thiamine Carl Roth
Tween-20 Sigma-Aldrich
Yeast extract Fluka
Buffers and media
Standard buffers Composition
ELISA coating buffer 0.159 g Na2CO3
(50 mM pH 9.6) 0.293 g NaHCO3
to 100 ml aqua dest.
ELISA blocking buffer PBS + 1 mg/ml BSA
ELISA wash buffer PBS + 0.05 % Tween-20
PBS 137 mM NaCl
2.7 mM KCl
10 mM Na2HPO4
2 mM KH2PO4
in aqua dest., for autoclaving
PEG/NaCl 200.0 g polyethylene glycol 8000
145.25 g NaCl
TAE 50x 242 g Tris-base
57.1 ml glacial acetic acid
100 ml 0.5 M sodium EDTA
to 1 L aqua dest.
dilute 1:50 for 1x TAE
TBS 50 mM Tris-HCl pH 7.5
150 mM NaCl
in aqua dest.
All buffers were freshly prepared before use. PEG/NaCl, PBS, TAE and TBS were
autoclaved for longer durability.
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Media for bacteria cultivation Composition
dYT Media 10 g Yeast Extract
16 g Bacto Tryptone
5 g NaCl
to 1 L aqua dest., for autoclaving
dYT Agar 15 g Agar-Agar
to 1 L dYT Medium, for autoclaving
M9 Agar 1.86 g Na2HPO4
0.93 g KH2PO4
20 g CaCl2
300g NH4SO4
20 g MgSO4×7 H2O
26.8 g H3BO3
18.1 g MnCl2×4 H2O
2.22 g ZnSO4×7 H2O
0.79 g CuSO4×5 H2O
10 g CoSO4
6 g C6H5FeO7
6 g C6H8O7×H2O
1 g EDTA
1 g thiamine
12.5 ml glucose
20 g agar-agar
to 1 L aqua dest., for autoclaving
All media were freshly prepared before use or stored at 4 ◦C. In this thesis, prepared M9
agar plates were used.
Antibiotics
Antibiotic stock solutions Composition
Ampicillin 100 mg/ml in aqua dest.
Antibiotic stock solutions were stored at -20 ◦C.
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Antibodies
Primary antibodies Concentration Provider
Mouse anti-M13 pVIII antibody,
monoclonal, IgG2a, clone RL-ph2
no statement Antibodies-online GmbH,
Germany
Mouse anti-M13 pIII antibody, mon-
oclonal, IgG, clone 10C3
0.5 mg/ml MoBiTec GmbH, Germany
Mouse anti-6X-his epitope tag anti-
body, monoclonal
1 mg/ml Thermo Fisher Scientific,
Germany
Secondary antibodies
Goat anti-mouse antibody, IgG,
DyLightT M 488 conjugated
1 mg/ml Thermo Fisher Scientific,
Germany
Goat anti-mouse antibody, IgG, poly-
clonal, Horseradish Peroxidase conju-
gated
0.82 mg/ml Sigma-Aldrich, Germany
Enzymes
Restriction
enzymes
Restriction Site Provider
BpmI (GsuI) 5’... CTGGAG (N) 16 ↓ ...3’ Thermo Fisher Scientific,
3’... GACCTC (N)14 ↑ ...5’ Germany
BglI 5’... GCCN NNN↓NGGC...3’ Thermo Fisher Scientific,
3’... CGGN↑NNN NCCG...5’ Germany
Ligases
T4 DNA Ligase Thermo Fisher Scientific,
Germany
Polymerases
Pfu polymerase Thermo Fisher Scientific,
Germany
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Primers
Samples A6_R2, A7_R2, PA6_R3, and PA6_R3 were amplified using the following
primers. Subsequently they were sent to LGC Genomics GmbH, Berlin, for NGS.
Panning Forward primer Reverse primer
A6_R2 TACTCGCTAT tttcgctaccgtagtgcag TACTCGCTAT ccactggtgccacctc
A7_R2 AGCATCGATG tttcgctaccgtagtgcag AGCATCGATG ccactggtgccacctc
PA6_R3 CATCGCTCGA tttcgctaccgtagtgcag CATCGCTCGA ccactggtgccacctc
PA7_R3 GTCTCACTGT tttcgctaccgtagtgcag GTCTCACTGT ccactggtgccacctc
Samples PA6_R3+NP and NP were directly sequenced at the Fraunhofer Institute for
Cell Therapy and Immunology, Leipzig, using the following primers, which consist of
adapter - index (XXXXXX) - sequencing primer - vector compatible sequence (small
letters).
Primer Sequence
Forward primer AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCT
ggctggtttcgctaccgtag
Reverse primer (specific) CAAGCAGAAGACGGCATACGAGAT XXXXXX
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT
acaccactggtgccacctc
XXXXXX = TGACCA for PA6_R3+NP
= ACAGTG for NP
Peptides
Peptide synthesis was performed by JPT Peptide Technologies GmbH, Berlin. All peptides
were biotinylated, the Biotin was coupled to the peptide by a Trioxatridecan-succinamic
acid (Ttds) linker. Furthermore, peptides 1, 3 and 4 were synthesized with a N-terminal
Glycine as it is present in the original phage displayed structure. Purity was set to be >
70 %, and 4 lyophilized aliquots were delivered per peptide. One aliquot was dissolved in
aqua dest. (1 mM), and stored as sub-aliquots at - 20 ◦C.
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Peptide sequence N-terminus C-terminus
1 GIWHSKQHPRPGR-Ttds-Lys(Biotin) amine amide
2 GVKHCIWRKCRP-Ttds-Lys(Biotin) amine amide
3 -Ttds-HPRPGR Biotine amide
4 -Ttds-GSIHQKHPGPWRR Biotin amide
A.2 Consensus sequence of NoVLP II.4 Grimsby VP1
MKMASNDANP SDGSTANLVP EVNNEVMALE PVVGAAIAAP VAGQQNVIDP
WIRNNFVQAP GGEFTVSPRN APGEILWSAP LGPDLNPYLS HLARMYNGYA
GGFEVQVILA GNAFTAGKII FAAVPPNFPT EGLSPSQVTM FPHIIVDVRQ
LEPVLIPLPD VRNNFYHYNQ SNDSTIKLIA MLYTPLRANN AGDDVFTVSC
RVLTRPSPDF DFIFLVPPTV ESRTKPFTVP ILTVEEMSNS RFPIPLEKLY
TGPSSAFVVQ PQNGRCTTDG VLLGTTQLSA VNICTFRGDV THIAGSHDYT
MNLASQNWNN YDPTEEIPAP LGTPDFVGKI QGMLTQTTRE DGSTRAHKAT
VSTGSVHFTP KLGSVQYTTD TNNDFQTGQN TKFTPVGVIQ DGNNHQNEPQ
QWVLPNYSGR TGHNVHLAPA VAPTFPGEQL LFFRSTMPGC SGYPNMNLDC
LLPQEWVQHF YQEAAPAQSD VALLRFVNPD TGRVLFECKL HKSGYVTVAH
TGPHDLVIPP NGYFRFDSWV NQFYTLAPMG NGAGRRRALE HHHHHH
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A.3 Additional results: micromixing channel structure
channel-no.
 1 to 8
100 !g/ml FITC  
bidistilled water  
Figure A.1: Proof-of-concept for a micromixing channel structure. Top: micromixing channel
structure to obtain a dilution gradient of fluorescein isothiocyanate (FITC) over 8 microfluidic
channels. Bottom: Signal-to-background ratio of the fluorescence intensity plotted over the
channel number for three different flow rates. Horizontal grey line represents the background
signal set to 1.
A micromixing channel structure was designed using the software CleWin 2.8., and
prepared by soft lithography (see Materials and Methods 3.5.7). It consisted of two inlets,
8 parallel microfluidic channels, and a joint outlet. Inlets and channels were connected
by a mixing structure. Width was set to 100µm for the mixing channels, and 400µm for
the parallel channels. Mixing of a fluorescent solution (100µg/ml FITC) and bidistilled
water was studied at three different flow rates.
In microfluidic channels, flow is laminar, and mixing will predominantly occur by diffusion.
Here, at a relatively high flow rate of 2µl/min, almost no mixing occurred, resulting in a
signal-to-background ratio (SBR) of 1.45 - 1.5 for the three channels closest to the FITC
inlet (no. 1, 2, and 3), and a SBR of approximately 1.1 for the three channels closest to
the water inlet (no. 6, 7, and 8). Only the SBRs of the most central channels (no. 4 and
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5) were slightly approaching each other (SBR 1.4 and 1.2, respectively). At the lower flow
rates (0.1 and 0.05µl/min), a similar result was observed. The SBR for channels 1 to 3
was also at an uniform level, but only about 1.3 for 0.1µl/min, and 1.2 for 0.5µl/min.
Therefore, difference to the minimal SBR level of channels 6 to 8 was smaller, resulting
in a more constant decrease of SBR.
In the extreme case of no flow, all channels should show the same signal due to diffusion.
Here, a flow rate of 0.1µl/min seemed to be optimal for obtaining a dilution gradient,
starting from channel-no. 3, up to no. 6. Thereby, a gradual decrease over 4 different
concentrations could be tested based on one starting concentration.
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